{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "30",
                "@timestamp": "2023-06-30T13:39:03.000003-04:00",
                "@year": "2023",
                "@month": "06"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2020",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding-addon-generated-timestamp": "2021-05-30T09:17:24.906Z",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Neuroradiology"},
                                {"$": "Department of Diagnostic Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125772166"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2006001738-0fb03a533cf3f3c62cfb2805860ced02",
                            "ce:source-text": "Division of Neuroradiology, Department of Diagnostic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125772166"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "T.",
                                "ce:initials": "T.",
                                "ce:surname": "Sananmuang",
                                "ce:indexed-name": "Sananmuang T."
                            },
                            "@author-instance-id": "2006001738-68bb096416543b6bc8f0c19eb094a7b2",
                            "@seq": "1",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD",
                            "ce:surname": "Sananmuang",
                            "@auid": "57219223585",
                            "ce:indexed-name": "Sananmuang T."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Neuroradiology"},
                                {"$": "Department of Radiology"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "113647143"
                            },
                            "@affiliation-instance-id": "2006001738-5ab0d96bb76b3b660cbec6bf0545b1e1",
                            "ce:source-text": "Division of Neuroradiology, Department of Radiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                            "@dptid": "113647143"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S.",
                                "ce:initials": "S.",
                                "ce:surname": "Prakkamakul",
                                "ce:indexed-name": "Prakkamakul S."
                            },
                            "@author-instance-id": "2006001738-49a2015b45e8fb6e89f1286e559c93af",
                            "@seq": "2",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Prakkamakul",
                            "@auid": "55788265500",
                            "ce:indexed-name": "Prakkamakul S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60022183",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Department of Radiology"},
                                {"$": "King Chulalongkorn Memorial Hospital"},
                                {"$": "the Thai Red Cross Society"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60022183",
                                    "@dptid": "104136224"
                                },
                                {"@afid": "60031780"}
                            ],
                            "@affiliation-instance-id": "2006001738-4b6c8223370e4d0466afc40ba5b8415f",
                            "ce:source-text": "Department of Radiology, King Chulalongkorn Memorial Hospital, the Thai Red Cross Society, Bangkok, Thailand",
                            "@dptid": "104136224"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S.",
                                "ce:initials": "S.",
                                "ce:surname": "Prakkamakul",
                                "ce:indexed-name": "Prakkamakul S."
                            },
                            "@author-instance-id": "2006001738-49a2015b45e8fb6e89f1286e559c93af",
                            "@seq": "2",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Prakkamakul",
                            "@auid": "55788265500",
                            "ce:indexed-name": "Prakkamakul S."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60199578",
                            "@country": "tha",
                            "city": "Bangkok",
                            "organization": [
                                {"$": "Division of Medical Oncology"},
                                {"$": "Department of Medicine"},
                                {"$": "Faculty of Medicine"},
                                {"$": "Ramathibodi Hospital"},
                                {"$": "Mahidol University"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60199578",
                                    "@dptid": "125763061"
                                },
                                {"@afid": "60012718"}
                            ],
                            "@affiliation-instance-id": "2006001738-fc91efc7b79d7e5e8d1e55fd99115bb5",
                            "ce:source-text": "Division of Medical Oncology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand",
                            "@dptid": "125763061"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "N.",
                                "ce:initials": "N.",
                                "ce:surname": "Ngampaiboon",
                                "ce:indexed-name": "Ngampaiboon N."
                            },
                            "@author-instance-id": "2006001738-1e3bf00ba19ddc9fa753413335055daf",
                            "@seq": "3",
                            "ce:initials": "N.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Ngampaiboon",
                            "@auid": "57221996014",
                            "ce:indexed-name": "Ngampaiboon N."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60021600",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Department of Radiation Oncology"},
                                {"$": "Princess Margaret Cancer Centre"},
                                {"$": "University of Toronto"}
                            ],
                            "affiliation-id": [
                                {"@afid": "60021600"},
                                {"@afid": "60016849"},
                                {"@afid": "60027817"}
                            ],
                            "state": "ON",
                            "@affiliation-instance-id": "2006001738-ed060a3ae6b9d6051c0add672ec32497",
                            "ce:source-text": "Department of Radiation Oncology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "S. H.",
                                "ce:initials": "S.H.",
                                "ce:surname": "Huang",
                                "ce:indexed-name": "Huang S.H."
                            },
                            "@author-instance-id": "2006001738-69f2366645fc3c2b5d8aec1ec92c96af",
                            "@seq": "4",
                            "ce:initials": "S.H.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Huang",
                            "@auid": "57202335059",
                            "ce:indexed-name": "Huang S.H."
                        }]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60016849",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Division of Neuroradiology"},
                                {"$": "Princess Margaret Cancer Centre"},
                                {"$": "University of Toronto"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60016849",
                                    "@dptid": "103868404"
                                },
                                {"@afid": "60027817"}
                            ],
                            "state": "ON",
                            "@affiliation-instance-id": "2006001738-f3c6bf07ebbf8c4861fe05acb56cb5b4",
                            "ce:source-text": "Division of Neuroradiology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada",
                            "@dptid": "103868404"
                        },
                        "author": [
                            {
                                "preferred-name": {
                                    "ce:given-name": "L.",
                                    "ce:initials": "L.",
                                    "ce:surname": "Alshafai",
                                    "ce:indexed-name": "Alshafai L."
                                },
                                "@author-instance-id": "2006001738-a14afa35e2483f586b72a98949b5b9a2",
                                "@seq": "5",
                                "ce:initials": "L.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Alshafai",
                                "@auid": "57189364833",
                                "ce:indexed-name": "Alshafai L."
                            },
                            {
                                "preferred-name": {
                                    "ce:given-name": "E.",
                                    "ce:initials": "E.",
                                    "ce:surname": "Yu From",
                                    "ce:indexed-name": "Yu From E."
                                },
                                "@author-instance-id": "2006001738-7a028ae31e4b417c6bee8c5b2baa918b",
                                "@seq": "6",
                                "ce:initials": "E.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Yu From",
                                "@auid": "57222001929",
                                "ce:indexed-name": "Yu From E."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "Canada",
                            "@afid": "60006894",
                            "@country": "can",
                            "city": "Toronto",
                            "organization": [
                                {"$": "Division of Neuroradiology (L.A.)"},
                                {"$": "Mount Sinai Hospital and University Health Network"},
                                {"$": "University of Toronto"}
                            ],
                            "affiliation-id": [
                                {
                                    "@afid": "60006894",
                                    "@dptid": "126261159"
                                },
                                {"@afid": "60016849"},
                                {"@afid": "60014468"}
                            ],
                            "state": "ON",
                            "@affiliation-instance-id": "2006001738-f22ff7f750edc669b1d403d8f9f6ecda",
                            "ce:source-text": "Division of Neuroradiology (L.A.), Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, Ontario, Canada",
                            "@dptid": "126261159"
                        },
                        "author": [{
                            "preferred-name": {
                                "ce:given-name": "L.",
                                "ce:initials": "L.",
                                "ce:surname": "Alshafai",
                                "ce:indexed-name": "Alshafai L."
                            },
                            "@author-instance-id": "2006001738-a14afa35e2483f586b72a98949b5b9a2",
                            "@seq": "5",
                            "ce:initials": "L.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Alshafai",
                            "@auid": "57189364833",
                            "ce:indexed-name": "Alshafai L."
                        }]
                    }
                ],
                "citation-title": "Immune checkpoint inhibitor: An emerging treatment for head and neck cancer. a primer for the radiologist",
                "abstracts": "© 2020, American Society of Neuroradiology. All rights reserved.Immune checkpoint inhibitors have revolutionized treatment in many cancers, including head and neck squamous cell carcinoma. The number of drugs recently approved by the FDA and the European Medicine Agency is growing. Pembrolizumab and nivolumab, which are anti-programmed cell death protein 1 monoclonal antibodies, were first adopted in 2016 as the second-line treatment for recurrent or metastatic head and neck squamous cell carcinoma in patients with disease progression after platinum-based chemotherapy. Recently, pembrolizumab with or without platinum-based chemotherapy was approved as the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma. Imaging studies play an essential role in assessing treatment response and monitoring efficacy and safety during and after treatments. Given the rapid increase in the use of immunotherapy in head and neck squamous cell carcinoma, neuroradiologists need to be familiar with the unique features indicative of treatment response in addition to a broad array of immune-related adverse events to avoid misinterpreting secondary drug-related adverse effects as tumor progression or metastasis. Moreover, emerging imaging techniques, including molecular imaging and radiomics, in an effort to assess or gauge the likelihood of treatment response to immune checkpoint inhibitors, is an ongoing area of active research.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Neuroradiology"},
                            {"$": "Department of Diagnostic Radiology"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Ramathibodi Hospital"},
                            {"$": "Mahidol University"}
                        ],
                        "ce:source-text": "Division of Neuroradiology, Department of Diagnostic Radiology, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand"
                    },
                    "person": {
                        "ce:initials": "T.",
                        "ce:degrees": "MD",
                        "ce:surname": "Sananmuang",
                        "ce:indexed-name": "Sananmuang T."
                    }
                },
                "related-item": {
                    "itemid": {
                        "$": "2007173374",
                        "@idtype": "erratumPUI"
                    },
                    "citation-title": "Erratum: Immune checkpoint inhibitor: An emerging treatment for head and neck cancer. A primer for the radiologist (Neurographics, (2020) 10, 5-6, (284\u2013301), 10.3174/ng.2000016)",
                    "@type": "erratum",
                    "citation-info": {
                        "citation-type": {"@code": "er"},
                        "citation-language": {
                            "@language": "English",
                            "@xml:lang": "eng"
                        },
                        "abstract-language": {
                            "@language": "English",
                            "@xml:lang": "eng"
                        }
                    },
                    "source": {
                        "sourcetitle-abbrev": "Neurographics",
                        "website": {"ce:e-address": {
                            "$": "https://www.ingentaconnect.com/search/download?pub=infobike%3a%2f%2fasnr%2fng%2f2021%2f00000011%2f00000001%2fart00009&mimetype=application%2fpdf",
                            "@type": "email"
                        }},
                        "@country": "usa",
                        "translated-sourcetitle": {"@xml:lang": "eng"},
                        "issn": {
                            "$": "26378329",
                            "@type": "electronic"
                        },
                        "volisspag": {
                            "voliss": {
                                "@volume": "11",
                                "@issue": "1"
                            },
                            "pagerange": {"@first": "65"}
                        },
                        "@type": "j",
                        "publicationyear": {"@first": "2021"},
                        "publisher": {"publishername": "American Society of Neuroradiology"},
                        "sourcetitle": "Neurographics",
                        "publicationdate": {"year": "2021"}
                    },
                    "ce:doi": "10.3174/ng.2000016.1"
                },
                "citation-info": {
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Neurographics",
                    "website": {"ce:e-address": {
                        "$": "https://www.ingentaconnect.com/content/asnr/ng/2020/00000010/f0020005/art00004#",
                        "@type": "email"
                    }},
                    "@country": "usa",
                    "translated-sourcetitle": {"@xml:lang": "eng"},
                    "issn": {
                        "$": "26378329",
                        "@type": "electronic"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "10",
                            "@issue": "5-6"
                        },
                        "pagerange": {
                            "@first": "284",
                            "@last": "301"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2020"},
                    "publisher": {"publishername": "American Society of Neuroradiology"},
                    "sourcetitle": "Neurographics",
                    "@srcid": "21101034071",
                    "publicationdate": {
                        "year": "2020",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2020"
                        }
                    }
                },
                "enhancement": {"classificationgroup": {"classifications": [
                    {
                        "@type": "ASJC",
                        "classification": "2741"
                    },
                    {
                        "@type": "SUBJABBR",
                        "classification": "MEDI"
                    }
                ]}}
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2021 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "21",
                    "@timestamp": "BST 20:25:01",
                    "@year": "2021",
                    "@month": "05"
                }},
                "itemidlist": {
                    "itemid": [
                        {
                            "$": "2006001738",
                            "@idtype": "PUI"
                        },
                        {
                            "$": "931471925",
                            "@idtype": "CAR-ID"
                        },
                        {
                            "$": "20210834156",
                            "@idtype": "REAXYSCAR"
                        },
                        {
                            "$": "20210574128",
                            "@idtype": "SCOPUS"
                        },
                        {
                            "$": "20200013412762",
                            "@idtype": "TPA-ID"
                        },
                        {
                            "$": "85100905088",
                            "@idtype": "SCP"
                        },
                        {
                            "$": "85100905088",
                            "@idtype": "SGR"
                        }
                    ],
                    "ce:doi": "10.3174/ng.2000016"
                }
            },
            "tail": {"bibliography": {
                "@refcount": "127",
                "reference": [
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7\u201330. 10.3322/caac.21590",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Cancer statistics, 2020"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3322/caac.21590",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85077522581",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "70"},
                                "pagerange": {
                                    "@first": "7",
                                    "@last": "30"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RL",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel RL"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "KD",
                                    "@_fa": "true",
                                    "ce:surname": "Miller",
                                    "ce:indexed-name": "Miller KD"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Jemal",
                                    "ce:indexed-name": "Jemal A."
                                }
                            ]},
                            "ref-sourcetitle": "CA A Cancer J Clin"
                        },
                        "ce:source-text": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin 2020;70:7\u201330. 10.3322/caac.21590"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tangjaturonrasme N, Vatanasapt P, Bychkov A. Epidemiology of head and neck cancer in Thailand. Asia Pac J Clin Oncol 2018;14:16\u201322. 10.1111/ajco.12757",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Epidemiology of head and neck cancer in Thailand"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/ajco.12757",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85034035389",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "16",
                                    "@last": "22"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Tangjaturonrasme",
                                    "ce:indexed-name": "Tangjaturonrasme N"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "P",
                                    "@_fa": "true",
                                    "ce:surname": "Vatanasapt",
                                    "ce:indexed-name": "Vatanasapt P"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Bychkov",
                                    "ce:indexed-name": "Bychkov A."
                                }
                            ]},
                            "ref-sourcetitle": "Asia Pac J Clin Oncol"
                        },
                        "ce:source-text": "Tangjaturonrasme N, Vatanasapt P, Bychkov A. Epidemiology of head and neck cancer in Thailand. Asia Pac J Clin Oncol 2018;14:16\u201322. 10.1111/ajco.12757"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92: 709\u201320. 10.1093/jnci/92.9.709",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "Evidence for a causal association between human papillomavirus and a subset of head and neck cancers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jnci/92.9.709",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0034600339",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "92"},
                                "pagerange": {
                                    "@first": "709",
                                    "@last": "720"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ML",
                                        "@_fa": "true",
                                        "ce:surname": "Gillison",
                                        "ce:indexed-name": "Gillison ML"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "WM",
                                        "@_fa": "true",
                                        "ce:surname": "Koch",
                                        "ce:indexed-name": "Koch WM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RB",
                                        "@_fa": "true",
                                        "ce:surname": "Capone",
                                        "ce:indexed-name": "Capone RB"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 2000;92: 709\u201320. 10.1093/jnci/92.9.709"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Larsen TV, Hussmann D, Nielsen AL. PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer. Cancer Commun (Lond) 2019;39:30. 10.1186/s40880-019- 0376-6",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40880-019-0376-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85066820551",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {"@first": "30"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "TV",
                                    "@_fa": "true",
                                    "ce:surname": "Larsen",
                                    "ce:indexed-name": "Larsen TV"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D",
                                    "@_fa": "true",
                                    "ce:surname": "Hussmann",
                                    "ce:indexed-name": "Hussmann D"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AL.",
                                    "@_fa": "true",
                                    "ce:surname": "Nielsen",
                                    "ce:indexed-name": "Nielsen AL."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Commun (Lond)"
                        },
                        "ce:source-text": "Larsen TV, Hussmann D, Nielsen AL. PD-L1 and PD-L2 expression correlated genes in non-small-cell lung cancer. Cancer Commun (Lond) 2019;39:30. 10.1186/s40880-019- 0376-6"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Salazar CR, Anayannis N, Smith RV, et al. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer 2014;135:2404\u201312. 10.1002/ ijc.28876",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Combined P16 and human papillomavirus testing predicts head and neck cancer survival"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/ijc.28876",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84909981448",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "135"},
                                "pagerange": {
                                    "@first": "2404",
                                    "@last": "2412"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CR",
                                        "@_fa": "true",
                                        "ce:surname": "Salazar",
                                        "ce:indexed-name": "Salazar CR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Anayannis",
                                        "ce:indexed-name": "Anayannis N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "RV",
                                        "@_fa": "true",
                                        "ce:surname": "Smith",
                                        "ce:indexed-name": "Smith RV"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Cancer"
                        },
                        "ce:source-text": "Salazar CR, Anayannis N, Smith RV, et al. Combined P16 and human papillomavirus testing predicts head and neck cancer survival. Int J Cancer 2014;135:2404\u201312. 10.1002/ ijc.28876"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sivars L, Tanis E, Na¨ sman A, et al. Human papillomavirus as a diagnostic and prognostic tool in cancer of unknown primary in the head and neck region. Anticancer Res 2016;36:487\u201393.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Human papillomavirus as a diagnostic and prognostic tool in cancer of unknown primary in the head and neck region"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84962175651",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "487",
                                    "@last": "493"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Sivars",
                                        "ce:indexed-name": "Sivars L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Tanis",
                                        "ce:indexed-name": "Tanis E"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Na¨ sman",
                                        "ce:indexed-name": "Na sman A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Anticancer Res"
                        },
                        "ce:source-text": "Sivars L, Tanis E, Na¨ sman A, et al. Human papillomavirus as a diagnostic and prognostic tool in cancer of unknown primary in the head and neck region. Anticancer Res 2016;36:487\u201393."
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92\u201398. 10.1200/JCO.2003.01.008",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "ref-title": {"ref-titletext": "An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JCO.2003.01.008",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0037208591",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "92",
                                    "@last": "98"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "DJ",
                                        "@_fa": "true",
                                        "ce:surname": "Adelstein",
                                        "ce:indexed-name": "Adelstein DJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Li",
                                        "ce:indexed-name": "Li Y"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GL",
                                        "@_fa": "true",
                                        "ce:surname": "Adams",
                                        "ce:indexed-name": "Adams GL"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92\u201398. 10.1200/JCO.2003.01.008"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705\u201315. 10.1056/ NEJMoa070956",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2007"},
                            "ref-title": {"ref-titletext": "Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa070956",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "35548972994",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "357"},
                                "pagerange": {
                                    "@first": "1705",
                                    "@last": "1715"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MR",
                                        "@_fa": "true",
                                        "ce:surname": "Posner",
                                        "ce:indexed-name": "Posner MR"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DM",
                                        "@_fa": "true",
                                        "ce:surname": "Hershock",
                                        "ce:indexed-name": "Hershock DM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CR",
                                        "@_fa": "true",
                                        "ce:surname": "Blajman",
                                        "ce:indexed-name": "Blajman CR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Posner MR, Hershock DM, Blajman CR, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:1705\u201315. 10.1056/ NEJMoa070956"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cohen EEW, Bell RB, Bifulco CB, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer 2019;7:184. 10.1186/s40425-019-0662-5",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-019-0662-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85069212369",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "184"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EEW",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen EEW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RB",
                                        "@_fa": "true",
                                        "ce:surname": "Bell",
                                        "ce:indexed-name": "Bell RB"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CB",
                                        "@_fa": "true",
                                        "ce:surname": "Bifulco",
                                        "ce:indexed-name": "Bifulco CB"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Cohen EEW, Bell RB, Bifulco CB, et al. The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC). J Immunother Cancer 2019;7:184. 10.1186/s40425-019-0662-5"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Taberna M, Oliva M, Mesı´a R. Cetuximab-containing combinations in locally advanced and recurrent or metastatic head and neck squamous cell carcinoma. Front Oncol 2019;9:383. 10.3389/fonc.2019.00383",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cetuximab-containing combinations in locally advanced and recurrent or metastatic head and neck squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fonc.2019.00383",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85067669917",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "383"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Taberna",
                                    "ce:indexed-name": "Taberna M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Oliva",
                                    "ce:indexed-name": "Oliva M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Mesı´a",
                                    "ce:indexed-name": "Mesia R."
                                }
                            ]},
                            "ref-sourcetitle": "Front Oncol"
                        },
                        "ce:source-text": "Taberna M, Oliva M, Mesı´a R. Cetuximab-containing combinations in locally advanced and recurrent or metastatic head and neck squamous cell carcinoma. Front Oncol 2019;9:383. 10.3389/fonc.2019.00383"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl JMed 2008;359:1116\u201327. 10.1056/NEJMoa0802656",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "Platinum-based chemotherapy plus cetuximab in head and neck cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa0802656",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "51649085865",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "359"},
                                "pagerange": {
                                    "@first": "1116",
                                    "@last": "1127"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JB",
                                        "@_fa": "true",
                                        "ce:surname": "Vermorken",
                                        "ce:indexed-name": "Vermorken JB"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mesia",
                                        "ce:indexed-name": "Mesia R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Rivera",
                                        "ce:indexed-name": "Rivera F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl JMed"
                        },
                        "ce:source-text": "Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl JMed 2008;359:1116\u201327. 10.1056/NEJMoa0802656"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hodi FS, Ballinger M, Lyons B, et al. Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy. J Clin Oncol 2018;36:850\u201358. 10.1200/ JCO.2017.75.1644",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JCO.2017.75.1644",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85044243593",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {
                                    "@first": "850",
                                    "@last": "858"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "FS",
                                        "@_fa": "true",
                                        "ce:surname": "Hodi",
                                        "ce:indexed-name": "Hodi FS"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ballinger",
                                        "ce:indexed-name": "Ballinger M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Lyons",
                                        "ce:indexed-name": "Lyons B"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Oncol"
                        },
                        "ce:source-text": "Hodi FS, Ballinger M, Lyons B, et al. Immune-Modified Response Evaluation Criteria In Solid Tumors (imRECIST): Refining guidelines to assess the clinical benefit of cancer immunotherapy. J Clin Oncol 2018;36:850\u201358. 10.1200/ JCO.2017.75.1644"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. NEngl JMed 2016;375:1856\u201367. 10.1056/NEJMoa1602252",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Nivolumab for recurrent squamous-cell carcinoma of the head and neck"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1602252",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84994812847",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "375"},
                                "pagerange": {
                                    "@first": "1856",
                                    "@last": "1867"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RL",
                                        "@_fa": "true",
                                        "ce:surname": "Ferris",
                                        "ce:indexed-name": "Ferris RL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Blumenschein",
                                        "ce:indexed-name": "Blumenschein G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fayette",
                                        "ce:indexed-name": "Fayette J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "NEngl JMed"
                        },
                        "ce:source-text": "Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. NEngl JMed 2016;375:1856\u201367. 10.1056/NEJMoa1602252"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Seiwert TY, Burtness B, Mehra R, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial. Lancet Oncol 2016;17:956\u201365. 10.1016/S1470-2045(16) 30066-3",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(16)30066-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84969988424",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "17"},
                                "pagerange": {
                                    "@first": "956",
                                    "@last": "965"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TY",
                                        "@_fa": "true",
                                        "ce:surname": "Seiwert",
                                        "ce:indexed-name": "Seiwert TY"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Burtness",
                                        "ce:indexed-name": "Burtness B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Mehra",
                                        "ce:indexed-name": "Mehra R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Seiwert TY, Burtness B, Mehra R, et al. Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): An open-label, multicentre, phase 1b trial. Lancet Oncol 2016;17:956\u201365. 10.1016/S1470-2045(16) 30066-3"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gong J, Chehrazi-Raffle A, Reddi S, et al. Development of PD-1 and PD-L1 inhibitors as a formof cancer immunotherapy: A comprehensive review of registration trials and future considerations. J Immunother Cancer 2018;6:8. 10.1186/ s40425-018-0316-z",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Development of PD-1 and PD-L1 inhibitors as a formof cancer immunotherapy: A comprehensive review of registration trials and future considerations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-018-0316-z",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85040860527",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "8"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Gong",
                                        "ce:indexed-name": "Gong J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Chehrazi-Raffle",
                                        "ce:indexed-name": "Chehrazi-Raffle A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Reddi",
                                        "ce:indexed-name": "Reddi S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Gong J, Chehrazi-Raffle A, Reddi S, et al. Development of PD-1 and PD-L1 inhibitors as a formof cancer immunotherapy: A comprehensive review of registration trials and future considerations. J Immunother Cancer 2018;6:8. 10.1186/ s40425-018-0316-z"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cohen EEW, Soulie`res D, Le Tourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomised, open-label, phase 3 study. Lancet 2019;393:156\u201367. 10.1016/S0140- 6736(18)31999-8",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomised, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(18)31999-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85059907778",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "393"},
                                "pagerange": {
                                    "@first": "156",
                                    "@last": "167"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EEW",
                                        "@_fa": "true",
                                        "ce:surname": "Cohen",
                                        "ce:indexed-name": "Cohen EEW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Soulie`res",
                                        "ce:indexed-name": "Soulie`res D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Le Tourneau",
                                        "ce:indexed-name": "Le Tourneau C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Cohen EEW, Soulie`res D, Le Tourneau C, et al. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): A randomised, open-label, phase 3 study. Lancet 2019;393:156\u201367. 10.1016/S0140- 6736(18)31999-8"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Burtness B, Harrington KJ, Greil R, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study. Lancet 2019;394:1915\u201328. 10.1016/S0140-6736(19)32591-7",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S0140-6736(19)32591-7",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075142270",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "394"},
                                "pagerange": {
                                    "@first": "1915",
                                    "@last": "1928"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Burtness",
                                        "ce:indexed-name": "Burtness B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KJ",
                                        "@_fa": "true",
                                        "ce:surname": "Harrington",
                                        "ce:indexed-name": "Harrington KJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Greil",
                                        "ce:indexed-name": "Greil R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet"
                        },
                        "ce:source-text": "Burtness B, Harrington KJ, Greil R, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study. Lancet 2019;394:1915\u201328. 10.1016/S0140-6736(19)32591-7"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kulangara K, Zhang N, Corigliano E, et al. Clinical utility of the combined positive score for programmed death ligand- 1 expression and the approval of pembrolizumab for treatment of gastric cancer. Arch Pathol Lab Med 2019;143:330\u201337. 10.5858/arpa.2018-0043-OA",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Clinical utility of the combined positive score for programmed death ligand- 1 expression and the approval of pembrolizumab for treatment of gastric cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.5858/arpa.2018-0043-OA",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85061160547",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "143"},
                                "pagerange": {
                                    "@first": "330",
                                    "@last": "337"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Kulangara",
                                        "ce:indexed-name": "Kulangara K"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Corigliano",
                                        "ce:indexed-name": "Corigliano E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Arch Pathol Lab Med"
                        },
                        "ce:source-text": "Kulangara K, Zhang N, Corigliano E, et al. Clinical utility of the combined positive score for programmed death ligand- 1 expression and the approval of pembrolizumab for treatment of gastric cancer. Arch Pathol Lab Med 2019;143:330\u201337. 10.5858/arpa.2018-0043-OA"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Seidel JA, Otsuka A, Kabashima K. Anti-PD-1 and anti- CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations. Front Oncol 2018;8:86. 10.3389/fonc.2018.00086",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Anti-PD-1 and anti- CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fonc.2018.00086",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85044932853",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "86"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JA",
                                    "@_fa": "true",
                                    "ce:surname": "Seidel",
                                    "ce:indexed-name": "Seidel JA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Otsuka",
                                    "ce:indexed-name": "Otsuka A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Kabashima",
                                    "ce:indexed-name": "Kabashima K."
                                }
                            ]},
                            "ref-sourcetitle": "Front Oncol"
                        },
                        "ce:source-text": "Seidel JA, Otsuka A, Kabashima K. Anti-PD-1 and anti- CTLA-4 therapies in cancer: Mechanisms of action, efficacy, and limitations. Front Oncol 2018;8:86. 10.3389/fonc.2018.00086"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 2019;16:151\u201367. 10.1038/s41571-018-0142-8",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Cancer immunoediting and resistance to T cell-based immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41571-018-0142-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85058065042",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "151",
                                    "@last": "167"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JS",
                                    "@_fa": "true",
                                    "ce:surname": "O\u2019Donnell",
                                    "ce:indexed-name": "O'Donnell JS"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "MWL",
                                    "@_fa": "true",
                                    "ce:surname": "Teng",
                                    "ce:indexed-name": "Teng MWL"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MJ.",
                                    "@_fa": "true",
                                    "ce:surname": "Smyth",
                                    "ce:indexed-name": "Smyth MJ."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "O\u2019Donnell JS, Teng MWL, Smyth MJ. Cancer immunoediting and resistance to T cell-based immunotherapy. Nat Rev Clin Oncol 2019;16:151\u201367. 10.1038/s41571-018-0142-8"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ribatti D. The concept of immune surveillance against tumors. The first theories. Oncotarget 2017;8:7175\u201380. 10.18632/oncotarget.12739",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "The concept of immune surveillance against tumors. The first theories"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.18632/oncotarget.12739",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85010767471",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {
                                    "@first": "7175",
                                    "@last": "7180"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "ce:surname": "Ribatti",
                                "ce:indexed-name": "Ribatti D."
                            }]},
                            "ref-sourcetitle": "Oncotarget"
                        },
                        "ce:source-text": "Ribatti D. The concept of immune surveillance against tumors. The first theories. Oncotarget 2017;8:7175\u201380. 10.18632/oncotarget.12739"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Borcoman E, Nandikolla A, Long G, et al. Patterns of response and progression to immunotherapy. Am Soc Clin Oncol Educ Book 2018;38:169\u201378. 10.1200/EDBK_200643",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Patterns of response and progression to immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/EDBK_200643",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85057236245",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "169",
                                    "@last": "178"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Borcoman",
                                        "ce:indexed-name": "Borcoman E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Nandikolla",
                                        "ce:indexed-name": "Nandikolla A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Long",
                                        "ce:indexed-name": "Long G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am Soc Clin Oncol Educ Book"
                        },
                        "ce:source-text": "Borcoman E, Nandikolla A, Long G, et al. Patterns of response and progression to immunotherapy. Am Soc Clin Oncol Educ Book 2018;38:169\u201378. 10.1200/EDBK_200643"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Dromain C, Beigelman C, Pozzessere C, et al. Imaging of tumour response to immunotherapy. Eur Radiol Exp 2020;4:2. 10.1186/s41747-019-0134-1",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Imaging of tumour response to immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s41747-019-0134-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85077329698",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "4"},
                                "pagerange": {"@first": "2"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Dromain",
                                        "ce:indexed-name": "Dromain C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Beigelman",
                                        "ce:indexed-name": "Beigelman C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Pozzessere",
                                        "ce:indexed-name": "Pozzessere C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Radiol Exp"
                        },
                        "ce:source-text": "Dromain C, Beigelman C, Pozzessere C, et al. Imaging of tumour response to immunotherapy. Eur Radiol Exp 2020;4:2. 10.1186/s41747-019-0134-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Darvin P, Toor SM, Sasidharan Nair V, et al. Immune checkpoint inhibitors: Recent progress and potential biomarkers. Exp Mol Med 2018;50:1\u201311. 10.1038/ s12276-018-0191-1",
                        "@id": "24",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitors: Recent progress and potential biomarkers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s12276-018-0191-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85058727297",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "11"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Darvin",
                                        "ce:indexed-name": "Darvin P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Toor",
                                        "ce:indexed-name": "Toor SM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Sasidharan Nair",
                                        "ce:indexed-name": "Sasidharan Nair V"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Exp Mol Med"
                        },
                        "ce:source-text": "Darvin P, Toor SM, Sasidharan Nair V, et al. Immune checkpoint inhibitors: Recent progress and potential biomarkers. Exp Mol Med 2018;50:1\u201311. 10.1038/ s12276-018-0191-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kruger S, Ilmer M, Kobold S, et al. Advances in cancer immunotherapy 2019 - latest trends. J Exp Clin Cancer Res 2019;38:268. 10.1186/s13046-019-1266-0",
                        "@id": "25",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Advances in cancer immunotherapy 2019 - latest trends"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13046-019-1266-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85067621510",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {"@first": "268"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kruger",
                                        "ce:indexed-name": "Kruger S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Ilmer",
                                        "ce:indexed-name": "Ilmer M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Kobold",
                                        "ce:indexed-name": "Kobold S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Exp Clin Cancer Res"
                        },
                        "ce:source-text": "Kruger S, Ilmer M, Kobold S, et al. Advances in cancer immunotherapy 2019 - latest trends. J Exp Clin Cancer Res 2019;38:268. 10.1186/s13046-019-1266-0"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252\u201364. 10.1038/ nrc3239",
                        "@id": "26",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "The blockade of immune checkpoints in cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nrc3239",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84858766182",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "12"},
                                "pagerange": {
                                    "@first": "252",
                                    "@last": "264"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "DM.",
                                "@_fa": "true",
                                "ce:surname": "Pardoll",
                                "ce:indexed-name": "Pardoll DM."
                            }]},
                            "ref-sourcetitle": "Nat Rev Cancer"
                        },
                        "ce:source-text": "Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252\u201364. 10.1038/ nrc3239"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation. Immunity 2016;44:989\u20131004. 10.1016/ j.immuni.2016.05.001",
                        "@id": "27",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.immuni.2016.05.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84966832820",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "44"},
                                "pagerange": {
                                    "@first": "989",
                                    "@last": "1004"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AC",
                                    "@_fa": "true",
                                    "ce:surname": "Anderson",
                                    "ce:indexed-name": "Anderson AC"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N",
                                    "@_fa": "true",
                                    "ce:surname": "Joller",
                                    "ce:indexed-name": "Joller N"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "VK.",
                                    "@_fa": "true",
                                    "ce:surname": "Kuchroo",
                                    "ce:indexed-name": "Kuchroo VK."
                                }
                            ]},
                            "ref-sourcetitle": "Immunity"
                        },
                        "ce:source-text": "Anderson AC, Joller N, Kuchroo VK. Lag-3, Tim-3, and TIGIT: Co-inhibitory receptors with specialized functions in immune regulation. Immunity 2016;44:989\u20131004. 10.1016/ j.immuni.2016.05.001"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: Similarities, differences, and implications of their inhibition. Am J ClinOncol 2016;39:98\u2013106. 10.1097/COC.0000000000000239",
                        "@id": "28",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "CTLA-4 and PD-1 pathways: Similarities, differences, and implications of their inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/COC.0000000000000239",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84957839638",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "39"},
                                "pagerange": {
                                    "@first": "98",
                                    "@last": "106"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "EI",
                                    "@_fa": "true",
                                    "ce:surname": "Buchbinder",
                                    "ce:indexed-name": "Buchbinder EI"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Desai",
                                    "ce:indexed-name": "Desai A."
                                }
                            ]},
                            "ref-sourcetitle": "Am J ClinOncol"
                        },
                        "ce:source-text": "Buchbinder EI, Desai A. CTLA-4 and PD-1 pathways: Similarities, differences, and implications of their inhibition. Am J ClinOncol 2016;39:98\u2013106. 10.1097/COC.0000000000000239"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 2018;18:153\u201367. 10.1038/nri.2017.108",
                        "@id": "29",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "The diverse functions of the PD1 inhibitory pathway"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/nri.2017.108",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041484537",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "153",
                                    "@last": "167"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AH",
                                    "@_fa": "true",
                                    "ce:surname": "Sharpe",
                                    "ce:indexed-name": "Sharpe AH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "KE.",
                                    "@_fa": "true",
                                    "ce:surname": "Pauken",
                                    "ce:indexed-name": "Pauken KE."
                                }
                            ]},
                            "ref-sourcetitle": "Nat Rev Immunol"
                        },
                        "ce:source-text": "Sharpe AH, Pauken KE. The diverse functions of the PD1 inhibitory pathway. Nat Rev Immunol 2018;18:153\u201367. 10.1038/nri.2017.108"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lyford-Pike S, Peng S, Young GD, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPVassociated head and neck squamous cell carcinoma. Cancer Res 2013;73:1733\u201341. 10.1158/0008-5472.CAN-12-2384",
                        "@id": "30",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPVassociated head and neck squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/0008-5472.CAN-12-2384",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84875475811",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "1733",
                                    "@last": "1741"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lyford-Pike",
                                        "ce:indexed-name": "Lyford-Pike S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Peng",
                                        "ce:indexed-name": "Peng S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GD",
                                        "@_fa": "true",
                                        "ce:surname": "Young",
                                        "ce:indexed-name": "Young GD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Res"
                        },
                        "ce:source-text": "Lyford-Pike S, Peng S, Young GD, et al. Evidence for a role of the PD-1:PD-L1 pathway in immune resistance of HPVassociated head and neck squamous cell carcinoma. Cancer Res 2013;73:1733\u201341. 10.1158/0008-5472.CAN-12-2384"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bauml JM, Aggarwal C, Cohen RB. Immunotherapy for head and neck cancer: Where are we now and where are we going? Ann Transl Med 2019;7(suppl 3):S75. 10.21037/ atm.2019.03.58",
                        "@id": "31",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immunotherapy for head and neck cancer: Where are we now and where are we going?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.21037/atm.2019.03.58",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85086115244",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "S75"}
                            },
                            "ref-text": "(suppl 3)",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "JM",
                                    "@_fa": "true",
                                    "ce:surname": "Bauml",
                                    "ce:indexed-name": "Bauml JM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Aggarwal",
                                    "ce:indexed-name": "Aggarwal C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "RB.",
                                    "@_fa": "true",
                                    "ce:surname": "Cohen",
                                    "ce:indexed-name": "Cohen RB."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Transl Med"
                        },
                        "ce:source-text": "Bauml JM, Aggarwal C, Cohen RB. Immunotherapy for head and neck cancer: Where are we now and where are we going? Ann Transl Med 2019;7(suppl 3):S75. 10.21037/ atm.2019.03.58"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Di Giacomo AM, Danielli R, Guidoboni M, et al. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: Clinical and immunological evidence from three patient cases. Cancer Immunol Immunother 2009;58:1297\u2013306. 10.1007/s00262- 008-0642-y",
                        "@id": "32",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: Clinical and immunological evidence from three patient cases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00262-008-0642-y",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "67349182592",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "58"},
                                "pagerange": {
                                    "@first": "1297",
                                    "@last": "1306"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AM",
                                        "@_fa": "true",
                                        "ce:surname": "Di Giacomo",
                                        "ce:indexed-name": "Di Giacomo AM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Danielli",
                                        "ce:indexed-name": "Danielli R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Guidoboni",
                                        "ce:indexed-name": "Guidoboni M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Immunother"
                        },
                        "ce:source-text": "Di Giacomo AM, Danielli R, Guidoboni M, et al. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: Clinical and immunological evidence from three patient cases. Cancer Immunol Immunother 2009;58:1297\u2013306. 10.1007/s00262- 008-0642-y"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncol 2018;81:45\u201351. 10.1016/j. oraloncology.2018.04.008",
                        "@id": "33",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.oraloncology.2018.04.008",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85045465431",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "81"},
                                "pagerange": {
                                    "@first": "45",
                                    "@last": "51"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "RL",
                                        "@_fa": "true",
                                        "ce:surname": "Ferris",
                                        "ce:indexed-name": "Ferris RL"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Blumenschein",
                                        "ce:indexed-name": "Blumenschein G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Fayette",
                                        "ce:indexed-name": "Fayette J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oral Oncol"
                        },
                        "ce:source-text": "Ferris RL, Blumenschein G Jr, Fayette J, et al. Nivolumab vs investigator\u2019s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral Oncol 2018;81:45\u201351. 10.1016/j. oraloncology.2018.04.008"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kwak JJ, Tirumani SH, Van den Abbeele AD, et al. Cancer immunotherapy: Imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics 2015;35:424\u201337. 10.1148/rg.352140121",
                        "@id": "34",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy: Imaging assessment of novel treatment response patterns and immune-related adverse events"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1148/rg.352140121",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84924654943",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "424",
                                    "@last": "437"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kwak",
                                        "ce:indexed-name": "Kwak JJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Tirumani",
                                        "ce:indexed-name": "Tirumani SH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AD",
                                        "@_fa": "true",
                                        "ce:surname": "Van den Abbeele",
                                        "ce:indexed-name": "Van den Abbeele AD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Radiographics"
                        },
                        "ce:source-text": "Kwak JJ, Tirumani SH, Van den Abbeele AD, et al. Cancer immunotherapy: Imaging assessment of novel treatment response patterns and immune-related adverse events. Radiographics 2015;35:424\u201337. 10.1148/rg.352140121"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nishino M, Hatabu H, Hodi FS. Imaging of cancer immunotherapy: Current approaches and future directions. Radiology 2019;290:9\u201322. 10.1148/radiol.2018181349",
                        "@id": "35",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Imaging of cancer immunotherapy: Current approaches and future directions"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1148/radiol.2018181349",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85058902211",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "290"},
                                "pagerange": {
                                    "@first": "9",
                                    "@last": "22"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Nishino",
                                    "ce:indexed-name": "Nishino M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H",
                                    "@_fa": "true",
                                    "ce:surname": "Hatabu",
                                    "ce:indexed-name": "Hatabu H"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "FS.",
                                    "@_fa": "true",
                                    "ce:surname": "Hodi",
                                    "ce:indexed-name": "Hodi FS."
                                }
                            ]},
                            "ref-sourcetitle": "Radiology"
                        },
                        "ce:source-text": "Nishino M, Hatabu H, Hodi FS. Imaging of cancer immunotherapy: Current approaches and future directions. Radiology 2019;290:9\u201322. 10.1148/radiol.2018181349"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wang GX, Kurra V, Gainor JF, et al. Immune checkpoint inhibitor cancer therapy: Spectrum of imaging findings. Radiographics 2017;37:2132\u201344. 10.1148/rg.2017170085",
                        "@id": "36",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitor cancer therapy: Spectrum of imaging findings"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1148/rg.2017170085",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85034602520",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "2132",
                                    "@last": "2144"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "GX",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang GX"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Kurra",
                                        "ce:indexed-name": "Kurra V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Gainor",
                                        "ce:indexed-name": "Gainor JF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Radiographics"
                        },
                        "ce:source-text": "Wang GX, Kurra V, Gainor JF, et al. Immune checkpoint inhibitor cancer therapy: Spectrum of imaging findings. Radiographics 2017;37:2132\u201344. 10.1148/rg.2017170085"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Jia W, Gao Q, Han A, et al. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy. Cancer Biol Med 2019;16:655\u201370. 10.20892/j.issn.2095-3941.2019.0144",
                        "@id": "37",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.20892/j.issn.2095-3941.2019.0144",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85078510921",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "655",
                                    "@last": "670"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "W",
                                        "@_fa": "true",
                                        "ce:surname": "Jia",
                                        "ce:indexed-name": "Jia W"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "Q",
                                        "@_fa": "true",
                                        "ce:surname": "Gao",
                                        "ce:indexed-name": "Gao Q"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Han",
                                        "ce:indexed-name": "Han A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Biol Med"
                        },
                        "ce:source-text": "Jia W, Gao Q, Han A, et al. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy. Cancer Biol Med 2019;16:655\u201370. 10.20892/j.issn.2095-3941.2019.0144"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wolchok JD, Hoos A, O\u2019Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria. Clin Cancer Res 2009; 15:7412\u201320. 10.1158/1078-0432.CCR-09-1624",
                        "@id": "38",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-09-1624",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "73149092567",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "15"},
                                "pagerange": {
                                    "@first": "7412",
                                    "@last": "7420"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JD",
                                        "@_fa": "true",
                                        "ce:surname": "Wolchok",
                                        "ce:indexed-name": "Wolchok JD"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Hoos",
                                        "ce:indexed-name": "Hoos A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "O\u2019Day",
                                        "ce:indexed-name": "O'Day S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Wolchok JD, Hoos A, O\u2019Day S, et al. Guidelines for the evaluation of immune therapy activity in solid tumors: Immune-related response criteria. Clin Cancer Res 2009; 15:7412\u201320. 10.1158/1078-0432.CCR-09-1624"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Doumas S, Foukas PG, Economopoulou P, et al. Atypical patterns of responses in the era of immune checkpoint inhibitors in head and neck cancer. Oral Oncol 2020;100:104477. 10.1016/j.oraloncology.2019.104477",
                        "@id": "39",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Atypical patterns of responses in the era of immune checkpoint inhibitors in head and neck cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.oraloncology.2019.104477",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075998775",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "100"},
                                "pagerange": {"@first": "104477"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Doumas",
                                        "ce:indexed-name": "Doumas S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "PG",
                                        "@_fa": "true",
                                        "ce:surname": "Foukas",
                                        "ce:indexed-name": "Foukas PG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Economopoulou",
                                        "ce:indexed-name": "Economopoulou P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oral Oncol"
                        },
                        "ce:source-text": "Doumas S, Foukas PG, Economopoulou P, et al. Atypical patterns of responses in the era of immune checkpoint inhibitors in head and neck cancer. Oral Oncol 2020;100:104477. 10.1016/j.oraloncology.2019.104477"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Saaˆda-Bouzid E, Defaucheux C, Karabajakian A, et al. Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol 2017;28:1605\u201311. 10.1093/annonc/mdx178",
                        "@id": "40",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx178",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85026833456",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "1605",
                                    "@last": "1611"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Saaˆda-Bouzid",
                                        "ce:indexed-name": "Saada-Bouzid E"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Defaucheux",
                                        "ce:indexed-name": "Defaucheux C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Karabajakian",
                                        "ce:indexed-name": "Karabajakian A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Saaˆda-Bouzid E, Defaucheux C, Karabajakian A, et al. Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol 2017;28:1605\u201311. 10.1093/annonc/mdx178"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Frelaut M, Le Tourneau C, Borcoman E. Hyperprogression under immunotherapy. Int J Mol Sci 2019;20:2674. 10.3390/ ijms20112674",
                        "@id": "41",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Hyperprogression under immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/ijms20112674",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85066939580",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {"@first": "2674"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Frelaut",
                                    "ce:indexed-name": "Frelaut M"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "C",
                                    "@_fa": "true",
                                    "ce:surname": "Le Tourneau",
                                    "ce:indexed-name": "Le Tourneau C"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Borcoman",
                                    "ce:indexed-name": "Borcoman E."
                                }
                            ]},
                            "ref-sourcetitle": "Int J Mol Sci"
                        },
                        "ce:source-text": "Frelaut M, Le Tourneau C, Borcoman E. Hyperprogression under immunotherapy. Int J Mol Sci 2019;20:2674. 10.3390/ ijms20112674"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205\u201316. 10.1093/jnci/92.3.205",
                        "@id": "42",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/jnci/92.3.205",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "0034594628",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "92"},
                                "pagerange": {
                                    "@first": "205",
                                    "@last": "216"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Therasse",
                                        "ce:indexed-name": "Therasse P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SG",
                                        "@_fa": "true",
                                        "ce:surname": "Arbuck",
                                        "ce:indexed-name": "Arbuck SG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "EA",
                                        "@_fa": "true",
                                        "ce:surname": "Eisenhauer",
                                        "ce:indexed-name": "Eisenhauer EA"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Natl Cancer Inst"
                        },
                        "ce:source-text": "Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000;92:205\u201316. 10.1093/jnci/92.3.205"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228\u201347. 10.1016/j.ejca.2008.10.026",
                        "@id": "43",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ejca.2008.10.026",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "57849117384",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "228",
                                    "@last": "247"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "EA",
                                        "@_fa": "true",
                                        "ce:surname": "Eisenhauer",
                                        "ce:indexed-name": "Eisenhauer EA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Therasse",
                                        "ce:indexed-name": "Therasse P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Bogaerts",
                                        "ce:indexed-name": "Bogaerts J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228\u201347. 10.1016/j.ejca.2008.10.026"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nishino M, Giobbie-Hurder A, Gargano M, et al. Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements. Clin Cancer Res 2013;19:3936\u201343. 10.1158/1078-0432.CCR-13-0895",
                        "@id": "44",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/1078-0432.CCR-13-0895",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84881128653",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "3936",
                                    "@last": "3943"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Nishino",
                                        "ce:indexed-name": "Nishino M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Giobbie-Hurder",
                                        "ce:indexed-name": "Giobbie-Hurder A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Gargano",
                                        "ce:indexed-name": "Gargano M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Clin Cancer Res"
                        },
                        "ce:source-text": "Nishino M, Giobbie-Hurder A, Gargano M, et al. Developing a common language for tumor response to immunotherapy: Immune-related response criteria using unidimensional measurements. Clin Cancer Res 2013;19:3936\u201343. 10.1158/1078-0432.CCR-13-0895"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Seymour L, Bogaerts J, Perrone A, et al. iRECIST: Guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 2017;18:e143\u201352. 10.1016/S1470-2045(17)30074-8",
                        "@id": "45",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "iRECIST: Guidelines for response criteria for use in trials testing immunotherapeutics"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(17)30074-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85014322386",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "18"},
                                "pagerange": {
                                    "@first": "e143",
                                    "@last": "e152"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Seymour",
                                        "ce:indexed-name": "Seymour L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Bogaerts",
                                        "ce:indexed-name": "Bogaerts J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Perrone",
                                        "ce:indexed-name": "Perrone A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Seymour L, Bogaerts J, Perrone A, et al. iRECIST: Guidelines for response criteria for use in trials testing immunotherapeutics. Lancet Oncol 2017;18:e143\u201352. 10.1016/S1470-2045(17)30074-8"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 2018;378:158\u201368. 10.1056/NEJMra1703481",
                        "@id": "46",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune-related adverse events associated with immune checkpoint blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMra1703481",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85040654063",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "378"},
                                "pagerange": {
                                    "@first": "158",
                                    "@last": "168"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "MA",
                                    "@_fa": "true",
                                    "ce:surname": "Postow",
                                    "ce:indexed-name": "Postow MA"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "R",
                                    "@_fa": "true",
                                    "ce:surname": "Sidlow",
                                    "ce:indexed-name": "Sidlow R"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MD.",
                                    "@_fa": "true",
                                    "ce:surname": "Hellmann",
                                    "ce:indexed-name": "Hellmann MD."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med 2018;378:158\u201368. 10.1056/NEJMra1703481"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Shah M, Jomaa MK, Ferrarotto R, et al. Serious immunerelated adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review. Head Neck 2019;41:4036\u201350. 10.1002/hed.25911",
                        "@id": "47",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Serious immunerelated adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/hed.25911",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85070769205",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "41"},
                                "pagerange": {
                                    "@first": "4036",
                                    "@last": "4050"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MK",
                                        "@_fa": "true",
                                        "ce:surname": "Jomaa",
                                        "ce:indexed-name": "Jomaa MK"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrarotto",
                                        "ce:indexed-name": "Ferrarotto R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Head Neck"
                        },
                        "ce:source-text": "Shah M, Jomaa MK, Ferrarotto R, et al. Serious immunerelated adverse events in patients with head and neck cancer after checkpoint blockade: Systematic review. Head Neck 2019;41:4036\u201350. 10.1002/hed.25911"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Martins F, Sofiya L, Sykiotis GP, et al. Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance. Nat Rev Clin Oncol 2019;16:563\u201380. 10.1038/s41571-019-0218-0",
                        "@id": "48",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41571-019-0218-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85065986843",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "563",
                                    "@last": "580"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Martins",
                                        "ce:indexed-name": "Martins F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Sofiya",
                                        "ce:indexed-name": "Sofiya L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GP",
                                        "@_fa": "true",
                                        "ce:surname": "Sykiotis",
                                        "ce:indexed-name": "Sykiotis GP"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Rev Clin Oncol"
                        },
                        "ce:source-text": "Martins F, Sofiya L, Sykiotis GP, et al. Adverse effects of immune-checkpoint inhibitors: Epidemiology, management and surveillance. Nat Rev Clin Oncol 2019;16:563\u201380. 10.1038/s41571-019-0218-0"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Myers G. Immune-related adverse events of immune checkpoint inhibitors: A brief review. Curr Oncol 2018;25:342\u201347. 10.3747/co.25.4235",
                        "@id": "49",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Immune-related adverse events of immune checkpoint inhibitors: A brief review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3747/co.25.4235",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85056971935",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "25"},
                                "pagerange": {
                                    "@first": "342",
                                    "@last": "347"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "G.",
                                "@_fa": "true",
                                "ce:surname": "Myers",
                                "ce:indexed-name": "Myers G."
                            }]},
                            "ref-sourcetitle": "Curr Oncol"
                        },
                        "ce:source-text": "Myers G. Immune-related adverse events of immune checkpoint inhibitors: A brief review. Curr Oncol 2018;25:342\u201347. 10.3747/co.25.4235"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Khoja L, Day D,Wei-Wu Chen T, et al. Tumour- and classspecific patterns of immune-related adverse events of immune checkpoint inhibitors: A systematic review. Ann Oncol 2017;28:2377\u201385. 10.1093/annonc/mdx286",
                        "@id": "50",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Tumour- and classspecific patterns of immune-related adverse events of immune checkpoint inhibitors: A systematic review"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx286",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85030551079",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "2377",
                                    "@last": "2385"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Khoja",
                                        "ce:indexed-name": "Khoja L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "D",
                                        "@_fa": "true",
                                        "ce:surname": "Day",
                                        "ce:indexed-name": "Day D"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Wei-Wu Chen",
                                        "ce:indexed-name": "Wei-Wu Chen T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Khoja L, Day D,Wei-Wu Chen T, et al. Tumour- and classspecific patterns of immune-related adverse events of immune checkpoint inhibitors: A systematic review. Ann Oncol 2017;28:2377\u201385. 10.1093/annonc/mdx286"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Wang H, Mustafa A, Liu S, et al. Immune checkpoint inhibitor toxicity in head and neck cancer: From identification to management. Front Pharmacol 2019;10:1254. 10.3389/fphar.2019.01254",
                        "@id": "51",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitor toxicity in head and neck cancer: From identification to management"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fphar.2019.01254",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85074610363",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {"@first": "1254"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Mustafa",
                                        "ce:indexed-name": "Mustafa A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Liu",
                                        "ce:indexed-name": "Liu S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Pharmacol"
                        },
                        "ce:source-text": "Wang H, Mustafa A, Liu S, et al. Immune checkpoint inhibitor toxicity in head and neck cancer: From identification to management. Front Pharmacol 2019;10:1254. 10.3389/fphar.2019.01254"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Solinas C, Porcu M, De Silva P, et al. Cancer immunotherapy-associated hypophysitis. Semin Oncol 2018;45:181\u201386. 10.1053/j.seminoncol.2018.09.002",
                        "@id": "52",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Cancer immunotherapy-associated hypophysitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1053/j.seminoncol.2018.09.002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85055119412",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "181",
                                    "@last": "186"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Solinas",
                                        "ce:indexed-name": "Solinas C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Porcu",
                                        "ce:indexed-name": "Porcu M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "De Silva",
                                        "ce:indexed-name": "De Silva P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Semin Oncol"
                        },
                        "ce:source-text": "Solinas C, Porcu M, De Silva P, et al. Cancer immunotherapy-associated hypophysitis. Semin Oncol 2018;45:181\u201386. 10.1053/j.seminoncol.2018.09.002"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bertrand A, Kostine M, Barnetche T, et al. Immune related adverse events associated with anti-CTLA-4 antibodies: Systematic review and meta-analysis. BMC Med 2015;13:211. 10.1186/s12916-015-0455-8",
                        "@id": "53",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Immune related adverse events associated with anti-CTLA-4 antibodies: Systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s12916-015-0455-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84940746759",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {"@first": "211"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Bertrand",
                                        "ce:indexed-name": "Bertrand A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Kostine",
                                        "ce:indexed-name": "Kostine M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Barnetche",
                                        "ce:indexed-name": "Barnetche T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "BMC Med"
                        },
                        "ce:source-text": "Bertrand A, Kostine M, Barnetche T, et al. Immune related adverse events associated with anti-CTLA-4 antibodies: Systematic review and meta-analysis. BMC Med 2015;13:211. 10.1186/s12916-015-0455-8"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bronstein Y, Ng CS, Hwu P, et al. Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol 2011;197:W992\u2013 1000. 10.2214/AJR.10.6198",
                        "@id": "54",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.2214/AJR.10.6198",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "82455194995",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "197"},
                                "pagerange": {
                                    "@first": "W992",
                                    "@last": "1000"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Bronstein",
                                        "ce:indexed-name": "Bronstein Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CS",
                                        "@_fa": "true",
                                        "ce:surname": "Ng",
                                        "ce:indexed-name": "Ng CS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Hwu",
                                        "ce:indexed-name": "Hwu P"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AJR Am J Roentgenol"
                        },
                        "ce:source-text": "Bronstein Y, Ng CS, Hwu P, et al. Radiologic manifestations of immune-related adverse events in patients with metastatic melanoma undergoing anti-CTLA-4 antibody therapy. AJR Am J Roentgenol 2011;197:W992\u2013 1000. 10.2214/AJR.10.6198"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer 2019;7:306. 10.1186/s40425-019- 0805-8",
                        "@id": "55",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-019-0805-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075066525",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "306"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Das",
                                    "ce:indexed-name": "Das S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DB.",
                                    "@_fa": "true",
                                    "ce:surname": "Johnson",
                                    "ce:indexed-name": "Johnson DB."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Das S, Johnson DB. Immune-related adverse events and anti-tumor efficacy of immune checkpoint inhibitors. J Immunother Cancer 2019;7:306. 10.1186/s40425-019- 0805-8"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Xing P, Zhang F,Wang G, et al. Incidence rates of immunerelated adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVOþIPI: A systematic review and meta-analysis. J Immunother Cancer 2019;7:341. 10.1186/s40425-019-0779-6",
                        "@id": "56",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Incidence rates of immunerelated adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVOþIPI: A systematic review and meta-analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-019-0779-6",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85076011093",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {"@first": "341"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Xing",
                                        "ce:indexed-name": "Xing P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Wang",
                                        "ce:indexed-name": "Wang G"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Xing P, Zhang F,Wang G, et al. Incidence rates of immunerelated adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVOþIPI: A systematic review and meta-analysis. J Immunother Cancer 2019;7:341. 10.1186/s40425-019-0779-6"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Campredon P, Imbert P, Mouly C, et al. Severe inflammatory ophthalmopathy in a euthyroid patient during nivolumab treatment. Eur Thyroid J 2018;7:84\u201387. 10.1159/ 000485742",
                        "@id": "57",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Severe inflammatory ophthalmopathy in a euthyroid patient during nivolumab treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000485742",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85051276165",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "84",
                                    "@last": "87"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Campredon",
                                        "ce:indexed-name": "Campredon P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Imbert",
                                        "ce:indexed-name": "Imbert P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Mouly",
                                        "ce:indexed-name": "Mouly C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Thyroid J"
                        },
                        "ce:source-text": "Campredon P, Imbert P, Mouly C, et al. Severe inflammatory ophthalmopathy in a euthyroid patient during nivolumab treatment. Eur Thyroid J 2018;7:84\u201387. 10.1159/ 000485742"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Carter BW, Halpenny DF, Ginsberg MS, et al. Immunotherapy in non-small cell lung cancer treatment: Current status and the role of imaging. J Thorac Imaging 2017;32:300\u201312. 10.1097/RTI.0000000000000291",
                        "@id": "58",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Immunotherapy in non-small cell lung cancer treatment: Current status and the role of imaging"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/RTI.0000000000000291",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85030849530",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "32"},
                                "pagerange": {
                                    "@first": "300",
                                    "@last": "312"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "BW",
                                        "@_fa": "true",
                                        "ce:surname": "Carter",
                                        "ce:indexed-name": "Carter BW"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DF",
                                        "@_fa": "true",
                                        "ce:surname": "Halpenny",
                                        "ce:indexed-name": "Halpenny DF"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MS",
                                        "@_fa": "true",
                                        "ce:surname": "Ginsberg",
                                        "ce:indexed-name": "Ginsberg MS"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Thorac Imaging"
                        },
                        "ce:source-text": "Carter BW, Halpenny DF, Ginsberg MS, et al. Immunotherapy in non-small cell lung cancer treatment: Current status and the role of imaging. J Thorac Imaging 2017;32:300\u201312. 10.1097/RTI.0000000000000291"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tirumani SH, Ramaiya NH, Keraliya A, et al. Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res 2015;3:1185\u201392. 10.1158/2326-6066. CIR-15-0102",
                        "@id": "59",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2326-6066.CIR-15-0102",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84962476269",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "1185",
                                    "@last": "1192"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SH",
                                        "@_fa": "true",
                                        "ce:surname": "Tirumani",
                                        "ce:indexed-name": "Tirumani SH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "NH",
                                        "@_fa": "true",
                                        "ce:surname": "Ramaiya",
                                        "ce:indexed-name": "Ramaiya NH"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Keraliya",
                                        "ce:indexed-name": "Keraliya A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Tirumani SH, Ramaiya NH, Keraliya A, et al. Radiographic profiling of immune-related adverse events in advanced melanoma patients treated with ipilimumab. Cancer Immunol Res 2015;3:1185\u201392. 10.1158/2326-6066. CIR-15-0102"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Nogueira E, Newsom-Davis T, Morganstein DL. Immunotherapy- induced endocrinopathies: Assessment, management and monitoring. Ther Adv Endocrinol Metab 2019;10. 10.1177/2042018819896182",
                        "@id": "60",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immunotherapy- induced endocrinopathies: Assessment, management and monitoring"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/2042018819896182",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85077185508",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {"@first": "10"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E",
                                    "@_fa": "true",
                                    "ce:surname": "Nogueira",
                                    "ce:indexed-name": "Nogueira E"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Newsom-Davis",
                                    "ce:indexed-name": "Newsom-Davis T"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "DL.",
                                    "@_fa": "true",
                                    "ce:surname": "Morganstein",
                                    "ce:indexed-name": "Morganstein DL."
                                }
                            ]},
                            "ref-sourcetitle": "Ther Adv Endocrinol Metab"
                        },
                        "ce:source-text": "Nogueira E, Newsom-Davis T, Morganstein DL. Immunotherapy- induced endocrinopathies: Assessment, management and monitoring. Ther Adv Endocrinol Metab 2019;10. 10.1177/2042018819896182"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Chang L-S, Barroso-Sousa R, Tolaney SM, et al. Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 2019;40:17\u201365. 10.1210/er.2018- 00006",
                        "@id": "61",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Endocrine toxicity of cancer immunotherapy targeting immune checkpoints"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1210/er.2018-00006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85060197321",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "40"},
                                "pagerange": {
                                    "@first": "17",
                                    "@last": "65"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L-S",
                                        "@_fa": "true",
                                        "ce:surname": "Chang",
                                        "ce:indexed-name": "Chang L-S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Barroso-Sousa",
                                        "ce:indexed-name": "Barroso-Sousa R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Tolaney",
                                        "ce:indexed-name": "Tolaney SM"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Endocr Rev"
                        },
                        "ce:source-text": "Chang L-S, Barroso-Sousa R, Tolaney SM, et al. Endocrine toxicity of cancer immunotherapy targeting immune checkpoints. Endocr Rev 2019;40:17\u201365. 10.1210/er.2018- 00006"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ferrari SM, Fallahi P, Galetta F, et al. Thyroid disorders induced by checkpoint inhibitors. Rev Endocr Metab Disord 2018;19:325\u201333. 10.1007/s11154-018-9463-2",
                        "@id": "62",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Thyroid disorders induced by checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11154-018-9463-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85053830798",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "325",
                                    "@last": "333"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Ferrari",
                                        "ce:indexed-name": "Ferrari SM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Fallahi",
                                        "ce:indexed-name": "Fallahi P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Galetta",
                                        "ce:indexed-name": "Galetta F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Rev Endocr Metab Disord"
                        },
                        "ce:source-text": "Ferrari SM, Fallahi P, Galetta F, et al. Thyroid disorders induced by checkpoint inhibitors. Rev Endocr Metab Disord 2018;19:325\u201333. 10.1007/s11154-018-9463-2"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Park ESY, Rabinowits G, Hamnvik O-PR, et al. A case of Graves\u2019 ophthalmopathy associated with pembrolizumab (Keytruda) therapy. J AAPOS 2018;22:310\u201312. 10.1016/j. jaapos.2018.01.006",
                        "@id": "63",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A case of Graves\u2019 ophthalmopathy associated with pembrolizumab (Keytruda) therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jaapos.2018.01.006",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85046142519",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "310",
                                    "@last": "312"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "ESY",
                                        "@_fa": "true",
                                        "ce:surname": "Park",
                                        "ce:indexed-name": "Park ESY"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Rabinowits",
                                        "ce:indexed-name": "Rabinowits G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "O-PR",
                                        "@_fa": "true",
                                        "ce:surname": "Hamnvik",
                                        "ce:indexed-name": "Hamnvik O-PR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J AAPOS"
                        },
                        "ce:source-text": "Park ESY, Rabinowits G, Hamnvik O-PR, et al. A case of Graves\u2019 ophthalmopathy associated with pembrolizumab (Keytruda) therapy. J AAPOS 2018;22:310\u201312. 10.1016/j. jaapos.2018.01.006"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sagiv O, Kandl TJ, Thakar SD, et al. Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients. Ophthalmic Plast Reconstr Surg 2019;35:50\u201352. 10.1097/IOP.0000000000001161",
                        "@id": "64",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/IOP.0000000000001161",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85059500700",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "50",
                                    "@last": "52"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "O",
                                        "@_fa": "true",
                                        "ce:surname": "Sagiv",
                                        "ce:indexed-name": "Sagiv O"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "TJ",
                                        "@_fa": "true",
                                        "ce:surname": "Kandl",
                                        "ce:indexed-name": "Kandl TJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SD",
                                        "@_fa": "true",
                                        "ce:surname": "Thakar",
                                        "ce:indexed-name": "Thakar SD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ophthalmic Plast Reconstr Surg"
                        },
                        "ce:source-text": "Sagiv O, Kandl TJ, Thakar SD, et al. Extraocular muscle enlargement and thyroid eye disease-like orbital inflammation associated with immune checkpoint inhibitor therapy in cancer patients. Ophthalmic Plast Reconstr Surg 2019;35:50\u201352. 10.1097/IOP.0000000000001161"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lee H, Hodi FS, Giobbie-Hurder A, et al. Characterization of thyroid disorders in patients receiving immune checkpoint inhibition therapy. Cancer Immunol Res 2017;5:1133\u201340. 10.1158/2326-6066.CIR-17-0208",
                        "@id": "65",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Characterization of thyroid disorders in patients receiving immune checkpoint inhibition therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2326-6066.CIR-17-0208",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85037606593",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "1133",
                                    "@last": "1140"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FS",
                                        "@_fa": "true",
                                        "ce:surname": "Hodi",
                                        "ce:indexed-name": "Hodi FS"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Giobbie-Hurder",
                                        "ce:indexed-name": "Giobbie-Hurder A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Lee H, Hodi FS, Giobbie-Hurder A, et al. Characterization of thyroid disorders in patients receiving immune checkpoint inhibition therapy. Cancer Immunol Res 2017;5:1133\u201340. 10.1158/2326-6066.CIR-17-0208"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Alessandrino F, Shah HJ, Ramaiya NH. Multimodality imaging of endocrine immune related adverse events: A primer for radiologists. Clin Imaging 2018;50:96\u2013103. 10.1016/j.clinimag.2017.12.014",
                        "@id": "66",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Multimodality imaging of endocrine immune related adverse events: A primer for radiologists"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.clinimag.2017.12.014",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85040704560",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "50"},
                                "pagerange": {
                                    "@first": "96",
                                    "@last": "103"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Alessandrino",
                                    "ce:indexed-name": "Alessandrino F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "HJ",
                                    "@_fa": "true",
                                    "ce:surname": "Shah",
                                    "ce:indexed-name": "Shah HJ"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "NH.",
                                    "@_fa": "true",
                                    "ce:surname": "Ramaiya",
                                    "ce:indexed-name": "Ramaiya NH."
                                }
                            ]},
                            "ref-sourcetitle": "Clin Imaging"
                        },
                        "ce:source-text": "Alessandrino F, Shah HJ, Ramaiya NH. Multimodality imaging of endocrine immune related adverse events: A primer for radiologists. Clin Imaging 2018;50:96\u2013103. 10.1016/j.clinimag.2017.12.014"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Rhea L, Yoon JW, Jang S. Rapid development of Graves\u2019 ophthalmopathy after treatment with ipilimumab and recurrence with pembrolizumab in a patient with previously treated graves\u2019 disease. J Oncol Pract 2018;14:747\u201349. 10.1200/JOP.18.00442",
                        "@id": "67",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Rapid development of Graves\u2019 ophthalmopathy after treatment with ipilimumab and recurrence with pembrolizumab in a patient with previously treated graves\u2019 disease"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1200/JOP.18.00442",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85058602794",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "747",
                                    "@last": "749"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Rhea",
                                    "ce:indexed-name": "Rhea L"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JW",
                                    "@_fa": "true",
                                    "ce:surname": "Yoon",
                                    "ce:indexed-name": "Yoon JW"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Jang",
                                    "ce:indexed-name": "Jang S."
                                }
                            ]},
                            "ref-sourcetitle": "J Oncol Pract"
                        },
                        "ce:source-text": "Rhea L, Yoon JW, Jang S. Rapid development of Graves\u2019 ophthalmopathy after treatment with ipilimumab and recurrence with pembrolizumab in a patient with previously treated graves\u2019 disease. J Oncol Pract 2018;14:747\u201349. 10.1200/JOP.18.00442"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cukier P, Santini FC, Scaranti M, et al. Endocrine side effects of cancer immunotherapy. Endocr Relat Cancer 2017;24:T331\u201347. 10.1530/ERC-17-0358",
                        "@id": "68",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Endocrine side effects of cancer immunotherapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1530/ERC-17-0358",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041076967",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "T331",
                                    "@last": "T347"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Cukier",
                                        "ce:indexed-name": "Cukier P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "FC",
                                        "@_fa": "true",
                                        "ce:surname": "Santini",
                                        "ce:indexed-name": "Santini FC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Scaranti",
                                        "ce:indexed-name": "Scaranti M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Endocr Relat Cancer"
                        },
                        "ce:source-text": "Cukier P, Santini FC, Scaranti M, et al. Endocrine side effects of cancer immunotherapy. Endocr Relat Cancer 2017;24:T331\u201347. 10.1530/ERC-17-0358"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Haanen JBAG, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv119\u201342. 10.1093/annonc/mdx225",
                        "@id": "69",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdx225",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85029704664",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "iv119",
                                    "@last": "iv142"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JBAG",
                                        "@_fa": "true",
                                        "ce:surname": "Haanen",
                                        "ce:indexed-name": "Haanen JBAG"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Carbonnel",
                                        "ce:indexed-name": "Carbonnel F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Robert",
                                        "ce:indexed-name": "Robert C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Haanen JBAG, Carbonnel F, Robert C, et al. Management of toxicities from immunotherapy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017;28:iv119\u201342. 10.1093/annonc/mdx225"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Eggermont AMM, Chiarion-Sileni V, Grob J-J, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial. Lancet Oncol 2015;16:522\u201330. 10.1016/S1470-2045(15)70122-1",
                        "@id": "70",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(15)70122-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84933678156",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "522",
                                    "@last": "530"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AMM",
                                        "@_fa": "true",
                                        "ce:surname": "Eggermont",
                                        "ce:indexed-name": "Eggermont AMM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "V",
                                        "@_fa": "true",
                                        "ce:surname": "Chiarion-Sileni",
                                        "ce:indexed-name": "Chiarion-Sileni V"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "J-J",
                                        "@_fa": "true",
                                        "ce:surname": "Grob",
                                        "ce:indexed-name": "Grob J-J"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Eggermont AMM, Chiarion-Sileni V, Grob J-J, et al. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): A randomised, double-blind, phase 3 trial. Lancet Oncol 2015;16:522\u201330. 10.1016/S1470-2045(15)70122-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Robert C, Schachter J, Long GV, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015;372:2521\u201332. 10.1056/NEJMoa1503093",
                        "@id": "71",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Pembrolizumab versus ipilimumab in advanced melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1503093",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84929481481",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "372"},
                                "pagerange": {
                                    "@first": "2521",
                                    "@last": "2532"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Robert",
                                        "ce:indexed-name": "Robert C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Schachter",
                                        "ce:indexed-name": "Schachter J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GV",
                                        "@_fa": "true",
                                        "ce:surname": "Long",
                                        "ce:indexed-name": "Long GV"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Robert C, Schachter J, Long GV, et al. Pembrolizumab versus ipilimumab in advanced melanoma. N Engl J Med 2015;372:2521\u201332. 10.1056/NEJMoa1503093"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 2017;377:1824\u201335. 10.1056/ NEJMoa1709030",
                        "@id": "72",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMoa1709030",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85033400433",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "377"},
                                "pagerange": {
                                    "@first": "1824",
                                    "@last": "1835"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Weber",
                                        "ce:indexed-name": "Weber J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Mandala",
                                        "ce:indexed-name": "Mandala M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Del Vecchio",
                                        "ce:indexed-name": "Del Vecchio M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Weber J, Mandala M, Del Vecchio M, et al. Adjuvant nivolumab versus ipilimumab in resected stage III or IV melanoma. N Engl J Med 2017;377:1824\u201335. 10.1056/ NEJMoa1709030"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Caturegli P, Di Dalmazi G, Lombardi M, et al. Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: Insights into pathogenesis from an autopsy series. Am J Pathol 2016;186:3225\u201335. 10.1016/j.ajpath. 2016.08.020",
                        "@id": "73",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: Insights into pathogenesis from an autopsy series"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ajpath.2016.08.020",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84995906230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "186"},
                                "pagerange": {
                                    "@first": "3225",
                                    "@last": "3235"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Caturegli",
                                        "ce:indexed-name": "Caturegli P"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Di Dalmazi",
                                        "ce:indexed-name": "Di Dalmazi G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lombardi",
                                        "ce:indexed-name": "Lombardi M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Am J Pathol"
                        },
                        "ce:source-text": "Caturegli P, Di Dalmazi G, Lombardi M, et al. Hypophysitis secondary to cytotoxic T-lymphocyte-associated protein 4 blockade: Insights into pathogenesis from an autopsy series. Am J Pathol 2016;186:3225\u201335. 10.1016/j.ajpath. 2016.08.020"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl JMed 2015;373:1270\u201371. 10.1056/NEJMc1509660",
                        "@id": "74",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Combined nivolumab and ipilimumab or monotherapy in untreated melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1056/NEJMc1509660",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84942089321",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "373"},
                                "pagerange": {
                                    "@first": "1270",
                                    "@last": "1271"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Larkin",
                                    "ce:indexed-name": "Larkin J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "FS",
                                    "@_fa": "true",
                                    "ce:surname": "Hodi",
                                    "ce:indexed-name": "Hodi FS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "JD.",
                                    "@_fa": "true",
                                    "ce:surname": "Wolchok",
                                    "ce:indexed-name": "Wolchok JD."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl JMed"
                        },
                        "ce:source-text": "Larkin J, Hodi FS, Wolchok JD. Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N Engl JMed 2015;373:1270\u201371. 10.1056/NEJMc1509660"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Faje A. Immunotherapy and hypophysitis: Clinical presentation, treatment, and biologic insights. Pituitary 2016;19:82\u201392. 10.1007/s11102-015-0671-4",
                        "@id": "75",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Immunotherapy and hypophysitis: Clinical presentation, treatment, and biologic insights"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11102-015-0671-4",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84954389695",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "82",
                                    "@last": "92"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "A.",
                                "@_fa": "true",
                                "ce:surname": "Faje",
                                "ce:indexed-name": "Faje A."
                            }]},
                            "ref-sourcetitle": "Pituitary"
                        },
                        "ce:source-text": "Faje A. Immunotherapy and hypophysitis: Clinical presentation, treatment, and biologic insights. Pituitary 2016;19:82\u201392. 10.1007/s11102-015-0671-4"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Garon-Czmil J, Petitpain N, Rouby F, et al. Immune check point inhibitors-induced hypophysitis: A retrospective analysis of the French Pharmacovigilance database. Sci Rep 2019;9:19419. 10.1038/s41598-019-56026-5",
                        "@id": "76",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune check point inhibitors-induced hypophysitis: A retrospective analysis of the French Pharmacovigilance database"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41598-019-56026-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85076895113",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "19419"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Garon-Czmil",
                                        "ce:indexed-name": "Garon-Czmil J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Petitpain",
                                        "ce:indexed-name": "Petitpain N"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Rouby",
                                        "ce:indexed-name": "Rouby F"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Sci Rep"
                        },
                        "ce:source-text": "Garon-Czmil J, Petitpain N, Rouby F, et al. Immune check point inhibitors-induced hypophysitis: A retrospective analysis of the French Pharmacovigilance database. Sci Rep 2019;9:19419. 10.1038/s41598-019-56026-5"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Carpenter KJ, Murtagh RD, Lilienfeld H, et al. Ipilimumab-induced hypophysitis: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1751\u201353. 10.3174/ajnr. A1623",
                        "@id": "77",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2009"},
                            "ref-title": {"ref-titletext": "Ipilimumab-induced hypophysitis: MR imaging findings"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3174/ajnr.A1623",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "70349897078",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "1751",
                                    "@last": "1753"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "KJ",
                                        "@_fa": "true",
                                        "ce:surname": "Carpenter",
                                        "ce:indexed-name": "Carpenter KJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RD",
                                        "@_fa": "true",
                                        "ce:surname": "Murtagh",
                                        "ce:indexed-name": "Murtagh RD"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "Lilienfeld",
                                        "ce:indexed-name": "Lilienfeld H"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AJNR Am J Neuroradiol"
                        },
                        "ce:source-text": "Carpenter KJ, Murtagh RD, Lilienfeld H, et al. Ipilimumab-induced hypophysitis: MR imaging findings. AJNR Am J Neuroradiol 2009;30:1751\u201353. 10.3174/ajnr. A1623"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cuzzubbo S, Javeri F, Tissier M, et al. Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature. Eur J Cancer 2017;73:1\u20138. 10.1016/j. ejca.2016.12.001",
                        "@id": "78",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.ejca.2016.12.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85008315530",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "8"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Cuzzubbo",
                                        "ce:indexed-name": "Cuzzubbo S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Javeri",
                                        "ce:indexed-name": "Javeri F"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Tissier",
                                        "ce:indexed-name": "Tissier M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur J Cancer"
                        },
                        "ce:source-text": "Cuzzubbo S, Javeri F, Tissier M, et al. Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature. Eur J Cancer 2017;73:1\u20138. 10.1016/j. ejca.2016.12.001"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Dalakas MC. Neurological complications of immune checkpoint inhibitors: What happens when you\u2019take the brakes off\u2019 the immune system. Ther Adv Neurol Disord 2018;11:1756286418799864. 10.1177/1756286418799864",
                        "@id": "79",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Neurological complications of immune checkpoint inhibitors: What happens when you\u2019take the brakes off\u2019 the immune system"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1756286418799864",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85054787483",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {"@first": "1756286418799864"}
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "MC.",
                                "@_fa": "true",
                                "ce:surname": "Dalakas",
                                "ce:indexed-name": "Dalakas MC."
                            }]},
                            "ref-sourcetitle": "Ther Adv Neurol Disord"
                        },
                        "ce:source-text": "Dalakas MC. Neurological complications of immune checkpoint inhibitors: What happens when you\u2019take the brakes off\u2019 the immune system. Ther Adv Neurol Disord 2018;11:1756286418799864. 10.1177/1756286418799864"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 2016;29:806\u201312. 10.1097/WCO.0000000000000391",
                        "@id": "80",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Neurologic complications of immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/WCO.0000000000000391",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84988602795",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "806",
                                    "@last": "812"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "AF.",
                                "@_fa": "true",
                                "ce:surname": "Hottinger",
                                "ce:indexed-name": "Hottinger AF."
                            }]},
                            "ref-sourcetitle": "Curr Opin Neurol"
                        },
                        "ce:source-text": "Hottinger AF. Neurologic complications of immune checkpoint inhibitors. Curr Opin Neurol 2016;29:806\u201312. 10.1097/WCO.0000000000000391"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Pan PC-W, Haggiagi A. Neurologic immune-related adverse events associated with immune checkpoint inhibition. Curr Oncol Rep 2019;21:108. 10.1007/s11912-019-0859-2",
                        "@id": "81",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Neurologic immune-related adverse events associated with immune checkpoint inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11912-019-0859-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075680257",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {"@first": "108"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "PC-W",
                                    "@_fa": "true",
                                    "ce:surname": "Pan",
                                    "ce:indexed-name": "Pan PC-W"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Haggiagi",
                                    "ce:indexed-name": "Haggiagi A."
                                }
                            ]},
                            "ref-sourcetitle": "Curr Oncol Rep"
                        },
                        "ce:source-text": "Pan PC-W, Haggiagi A. Neurologic immune-related adverse events associated with immune checkpoint inhibition. Curr Oncol Rep 2019;21:108. 10.1007/s11912-019-0859-2"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Shah S, Dunn-Pirio A, Luedke M, et al. Nivolumabinduced autoimmune encephalitis in two patients with lung adenocarcinoma. Case Rep Neurol Med 2018;2018. 10.1155/2018/2548528",
                        "@id": "82",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Nivolumabinduced autoimmune encephalitis in two patients with lung adenocarcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1155/2018/2548528",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85059160655",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"pagerange": {"@first": "2018"}},
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Shah",
                                        "ce:indexed-name": "Shah S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Dunn-Pirio",
                                        "ce:indexed-name": "Dunn-Pirio A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Luedke",
                                        "ce:indexed-name": "Luedke M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Case Rep Neurol Med"
                        },
                        "ce:source-text": "Shah S, Dunn-Pirio A, Luedke M, et al. Nivolumabinduced autoimmune encephalitis in two patients with lung adenocarcinoma. Case Rep Neurol Med 2018;2018. 10.1155/2018/2548528"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Spain L, Walls G, Julve M, et al. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: A single centre experience and review of the literature. Ann Oncol 2017;28:377\u201385. 10.1093/annonc/mdw558",
                        "@id": "83",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: A single centre experience and review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdw558",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85019549399",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "28"},
                                "pagerange": {
                                    "@first": "377",
                                    "@last": "385"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Spain",
                                        "ce:indexed-name": "Spain L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Walls",
                                        "ce:indexed-name": "Walls G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Julve",
                                        "ce:indexed-name": "Julve M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Spain L, Walls G, Julve M, et al. Neurotoxicity from immune-checkpoint inhibition in the treatment of melanoma: A single centre experience and review of the literature. Ann Oncol 2017;28:377\u201385. 10.1093/annonc/mdw558"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Fellner A, Makranz C, Lotem M, et al. Neurologic complications of immune checkpoint inhibitors. J Neurooncol 2018;137:601\u201309. 10.1007/s11060-018-2752-5",
                        "@id": "84",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Neurologic complications of immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s11060-018-2752-5",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041836926",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "137"},
                                "pagerange": {
                                    "@first": "601",
                                    "@last": "609"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Fellner",
                                        "ce:indexed-name": "Fellner A"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Makranz",
                                        "ce:indexed-name": "Makranz C"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lotem",
                                        "ce:indexed-name": "Lotem M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neurooncol"
                        },
                        "ce:source-text": "Fellner A, Makranz C, Lotem M, et al. Neurologic complications of immune checkpoint inhibitors. J Neurooncol 2018;137:601\u201309. 10.1007/s11060-018-2752-5"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD- 1) antibodies. JAMA Neurol 2017;74:1216\u201322. 10.1001/ jamaneurol.2017.1912",
                        "@id": "85",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Neurological complications associated with anti-programmed death 1 (PD- 1) antibodies"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1001/jamaneurol.2017.1912",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85031757174",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "74"},
                                "pagerange": {
                                    "@first": "1216",
                                    "@last": "1222"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "JC",
                                        "@_fa": "true",
                                        "ce:surname": "Kao",
                                        "ce:indexed-name": "Kao JC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Liao",
                                        "ce:indexed-name": "Liao B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "SN",
                                        "@_fa": "true",
                                        "ce:surname": "Markovic",
                                        "ce:indexed-name": "Markovic SN"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Neurol"
                        },
                        "ce:source-text": "Kao JC, Liao B, Markovic SN, et al. Neurological complications associated with anti-programmed death 1 (PD- 1) antibodies. JAMA Neurol 2017;74:1216\u201322. 10.1001/ jamaneurol.2017.1912"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Mo¨hn N, Beutel G, Gutzmer R, et al. Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy-review of the literature and future outlook. J Clin Med 2019;8:1777. 10.3390/jcm8111777",
                        "@id": "86",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy-review of the literature and future outlook"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3390/jcm8111777",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85079387556",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "1777"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Mo¨hn",
                                        "ce:indexed-name": "Mohn N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "G",
                                        "@_fa": "true",
                                        "ce:surname": "Beutel",
                                        "ce:indexed-name": "Beutel G"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Gutzmer",
                                        "ce:indexed-name": "Gutzmer R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Clin Med"
                        },
                        "ce:source-text": "Mo¨hn N, Beutel G, Gutzmer R, et al. Neurological immune related adverse events associated with nivolumab, ipilimumab, and pembrolizumab therapy-review of the literature and future outlook. J Clin Med 2019;8:1777. 10.3390/jcm8111777"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Brown MP, Hissaria P, Hsieh AH, et al. Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy. J Neuroimmunol 2017;305:16\u201318. 10.1016/j.jneuroim.2016.12.016",
                        "@id": "87",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.jneuroim.2016.12.016",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85010748396",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "305"},
                                "pagerange": {
                                    "@first": "16",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MP",
                                        "@_fa": "true",
                                        "ce:surname": "Brown",
                                        "ce:indexed-name": "Brown MP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Hissaria",
                                        "ce:indexed-name": "Hissaria P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AH",
                                        "@_fa": "true",
                                        "ce:surname": "Hsieh",
                                        "ce:indexed-name": "Hsieh AH"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Neuroimmunol"
                        },
                        "ce:source-text": "Brown MP, Hissaria P, Hsieh AH, et al. Autoimmune limbic encephalitis with anti-contactin-associated protein-like 2 antibody secondary to pembrolizumab therapy. J Neuroimmunol 2017;305:16\u201318. 10.1016/j.jneuroim.2016.12.016"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Larkin J, Chmielowski B, Lao CD, et al. Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis. Oncologist 2017;22:709\u201318. 10.1634/theoncologist.2016-0487",
                        "@id": "88",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1634/theoncologist.2016-0487",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85020881421",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "22"},
                                "pagerange": {
                                    "@first": "709",
                                    "@last": "718"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Larkin",
                                        "ce:indexed-name": "Larkin J"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Chmielowski",
                                        "ce:indexed-name": "Chmielowski B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "CD",
                                        "@_fa": "true",
                                        "ce:surname": "Lao",
                                        "ce:indexed-name": "Lao CD"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncologist"
                        },
                        "ce:source-text": "Larkin J, Chmielowski B, Lao CD, et al. Neurologic serious adverse events associated with nivolumab plus ipilimumab or nivolumab alone in advanced melanoma, including a case series of encephalitis. Oncologist 2017;22:709\u201318. 10.1634/theoncologist.2016-0487"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Salam S, Lavin T, Turan A. Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep 2016;2016:bcr2016215012. 10.1136/bcr- 2016-215012",
                        "@id": "89",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Limbic encephalitis following immunotherapy against metastatic malignant melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1136/bcr-2016-215012",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84962409041",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2016"},
                                "pagerange": {"@first": "bcr2016215012"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Salam",
                                    "ce:indexed-name": "Salam S"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Lavin",
                                    "ce:indexed-name": "Lavin T"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Turan",
                                    "ce:indexed-name": "Turan A."
                                }
                            ]},
                            "ref-sourcetitle": "BMJ Case Rep"
                        },
                        "ce:source-text": "Salam S, Lavin T, Turan A. Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep 2016;2016:bcr2016215012. 10.1136/bcr- 2016-215012"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Williams TJ, Benavides DR, Patrice K-A, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 2016;73:928\u201333. 10.1001/jamaneurol.2016.1399",
                        "@id": "90",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1001/jamaneurol.2016.1399",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84981271733",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "73"},
                                "pagerange": {
                                    "@first": "928",
                                    "@last": "933"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "TJ",
                                        "@_fa": "true",
                                        "ce:surname": "Williams",
                                        "ce:indexed-name": "Williams TJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "DR",
                                        "@_fa": "true",
                                        "ce:surname": "Benavides",
                                        "ce:indexed-name": "Benavides DR"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K-A",
                                        "@_fa": "true",
                                        "ce:surname": "Patrice",
                                        "ce:indexed-name": "Patrice K-A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "JAMA Neurol"
                        },
                        "ce:source-text": "Williams TJ, Benavides DR, Patrice K-A, et al. Association of autoimmune encephalitis with combined immune checkpoint inhibitor treatment for metastatic cancer. JAMA Neurol 2016;73:928\u201333. 10.1001/jamaneurol.2016.1399"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Zurko J, Mehta A. Association of immune-mediated cerebellitis with immune checkpoint inhibitor therapy. Mayo Clin Proc Innov Qual Outcomes 2018;2:74\u201377. 10.1016/j. mayocpiqo.2017.12.001",
                        "@id": "91",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Association of immune-mediated cerebellitis with immune checkpoint inhibitor therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.mayocpiqo.2017.12.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85070195284",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {
                                    "@first": "74",
                                    "@last": "77"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Zurko",
                                    "ce:indexed-name": "Zurko J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mehta",
                                    "ce:indexed-name": "Mehta A."
                                }
                            ]},
                            "ref-sourcetitle": "Mayo Clin Proc Innov Qual Outcomes"
                        },
                        "ce:source-text": "Zurko J, Mehta A. Association of immune-mediated cerebellitis with immune checkpoint inhibitor therapy. Mayo Clin Proc Innov Qual Outcomes 2018;2:74\u201377. 10.1016/j. mayocpiqo.2017.12.001"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Maurice C, Schneider R, Kiehl T-R, et al. Subacute CNS demyelination after treatment with nivolumab for melanoma. Cancer Immunol Res 2015;3:1299\u2013302. 10.1158/2326-6066.CIR-15-0141",
                        "@id": "92",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Subacute CNS demyelination after treatment with nivolumab for melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2326-6066.CIR-15-0141",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84962439197",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "1299",
                                    "@last": "1302"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Maurice",
                                        "ce:indexed-name": "Maurice C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Schneider",
                                        "ce:indexed-name": "Schneider R"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T-R",
                                        "@_fa": "true",
                                        "ce:surname": "Kiehl",
                                        "ce:indexed-name": "Kiehl T-R"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Maurice C, Schneider R, Kiehl T-R, et al. Subacute CNS demyelination after treatment with nivolumab for melanoma. Cancer Immunol Res 2015;3:1299\u2013302. 10.1158/2326-6066.CIR-15-0141"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cao Y, Nylander A, Ramanan S, et al. CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment. Neurology 2016;86:1553\u201356. 10.1212/WNL. 0000000000002594",
                        "@id": "93",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1212/WNL.0000000000002594",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84964335770",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "86"},
                                "pagerange": {
                                    "@first": "1553",
                                    "@last": "1556"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "Y",
                                        "@_fa": "true",
                                        "ce:surname": "Cao",
                                        "ce:indexed-name": "Cao Y"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Nylander",
                                        "ce:indexed-name": "Nylander A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Ramanan",
                                        "ce:indexed-name": "Ramanan S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neurology"
                        },
                        "ce:source-text": "Cao Y, Nylander A, Ramanan S, et al. CNS demyelination and enhanced myelin-reactive responses after ipilimumab treatment. Neurology 2016;86:1553\u201356. 10.1212/WNL. 0000000000002594"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gettings EJ, Hackett CT, Scott TF. Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma. Mult Scler 2015;21:670. 10.1177/ 1352458514549403",
                        "@id": "94",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1177/1352458514549403",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84952785505",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {"@first": "670"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "EJ",
                                    "@_fa": "true",
                                    "ce:surname": "Gettings",
                                    "ce:indexed-name": "Gettings EJ"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "CT",
                                    "@_fa": "true",
                                    "ce:surname": "Hackett",
                                    "ce:indexed-name": "Hackett CT"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "TF.",
                                    "@_fa": "true",
                                    "ce:surname": "Scott",
                                    "ce:indexed-name": "Scott TF."
                                }
                            ]},
                            "ref-sourcetitle": "Mult Scler"
                        },
                        "ce:source-text": "Gettings EJ, Hackett CT, Scott TF. Severe relapse in a multiple sclerosis patient associated with ipilimumab treatment of melanoma. Mult Scler 2015;21:670. 10.1177/ 1352458514549403"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Gerdes LA, Held K, Beltra´n E, et al. CTLA4 as immunological checkpoint in the development of multiple sclerosis. Ann Neurol 2016;80:294\u2013300. 10.1002/ana.24715",
                        "@id": "95",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "CTLA4 as immunological checkpoint in the development of multiple sclerosis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/ana.24715",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84981250350",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "80"},
                                "pagerange": {
                                    "@first": "294",
                                    "@last": "300"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LA",
                                        "@_fa": "true",
                                        "ce:surname": "Gerdes",
                                        "ce:indexed-name": "Gerdes LA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Held",
                                        "ce:indexed-name": "Held K"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Beltra´n",
                                        "ce:indexed-name": "Beltran E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Neurol"
                        },
                        "ce:source-text": "Gerdes LA, Held K, Beltra´n E, et al. CTLA4 as immunological checkpoint in the development of multiple sclerosis. Ann Neurol 2016;80:294\u2013300. 10.1002/ana.24715"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "La¨ubli H, Hench J, Stanczak M, et al. Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade. J Immunother Cancer 2017;5:46. 10.1186/s40425-017-0249-y",
                        "@id": "96",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-017-0249-y",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85021145360",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {"@first": "46"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "H",
                                        "@_fa": "true",
                                        "ce:surname": "La¨ubli",
                                        "ce:indexed-name": "Laubli H"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "J",
                                        "@_fa": "true",
                                        "ce:surname": "Hench",
                                        "ce:indexed-name": "Hench J"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Stanczak",
                                        "ce:indexed-name": "Stanczak M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "La¨ubli H, Hench J, Stanczak M, et al. Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade. J Immunother Cancer 2017;5:46. 10.1186/s40425-017-0249-y"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Feng J, Ross L, Ontaneda D. Pembrolizumab-induced CNS vasculitis. Neurology: Clinical Practice Nov 2019. 10.1212/ CPJ.0000000000000768",
                        "@id": "97",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Pembrolizumab-induced CNS vasculitis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1212/CPJ.0000000000000768",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85098720238",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-text": "Nov",
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "J",
                                    "@_fa": "true",
                                    "ce:surname": "Feng",
                                    "ce:indexed-name": "Feng J"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "L",
                                    "@_fa": "true",
                                    "ce:surname": "Ross",
                                    "ce:indexed-name": "Ross L"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Ontaneda",
                                    "ce:indexed-name": "Ontaneda D."
                                }
                            ]},
                            "ref-sourcetitle": "Neurology: Clinical Practice"
                        },
                        "ce:source-text": "Feng J, Ross L, Ontaneda D. Pembrolizumab-induced CNS vasculitis. Neurology: Clinical Practice Nov 2019. 10.1212/ CPJ.0000000000000768"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Lanfranchi M, Lee EQ, Buchbinder E, et al. Pembrolizumabrelated neuroinflammation: A case report and review of the literature.Neurographics 2018;8(2):119\u201323. 10.3174/ng.9170234",
                        "@id": "98",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Pembrolizumabrelated neuroinflammation: A case report and review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3174/ng.9170234",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85075697635",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "8",
                                    "@issue": "2"
                                },
                                "pagerange": {
                                    "@first": "119",
                                    "@last": "123"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Lanfranchi",
                                        "ce:indexed-name": "Lanfranchi M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EQ",
                                        "@_fa": "true",
                                        "ce:surname": "Lee",
                                        "ce:indexed-name": "Lee EQ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "E",
                                        "@_fa": "true",
                                        "ce:surname": "Buchbinder",
                                        "ce:indexed-name": "Buchbinder E"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neurographics"
                        },
                        "ce:source-text": "Lanfranchi M, Lee EQ, Buchbinder E, et al. Pembrolizumabrelated neuroinflammation: A case report and review of the literature.Neurographics 2018;8(2):119\u201323. 10.3174/ng.9170234"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Conry RM, Sullivan JC, Nabors LB III. Ipilimumabinduced encephalopathy with a reversible splenial lesion. Cancer Immunol Res 2015;3:598\u2013601. 10.1158/2326-6066. CIR-15-0035",
                        "@id": "99",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Ipilimumabinduced encephalopathy with a reversible splenial lesion"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1158/2326-6066.CIR-15-0035",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84961875164",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "598",
                                    "@last": "601"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "RM",
                                    "@_fa": "true",
                                    "ce:surname": "Conry",
                                    "ce:indexed-name": "Conry RM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "JC",
                                    "@_fa": "true",
                                    "ce:surname": "Sullivan",
                                    "ce:indexed-name": "Sullivan JC"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "LB",
                                    "@_fa": "true",
                                    "ce:surname": "Nabors",
                                    "ce:indexed-name": "Nabors LB"
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Immunol Res"
                        },
                        "ce:source-text": "Conry RM, Sullivan JC, Nabors LB III. Ipilimumabinduced encephalopathy with a reversible splenial lesion. Cancer Immunol Res 2015;3:598\u2013601. 10.1158/2326-6066. CIR-15-0035"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Voskens CJ, Goldinger SM, Loquai C, et al. The price of tumor control: An analysis of rare side effects of anti- CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One 2013;8:e53745. 10.1371/ journal.pone.0053745",
                        "@id": "100",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2013"},
                            "ref-title": {"ref-titletext": "The price of tumor control: An analysis of rare side effects of anti- CTLA-4 therapy in metastatic melanoma from the ipilimumab network"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1371/journal.pone.0053745",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84872339660",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "e53745"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CJ",
                                        "@_fa": "true",
                                        "ce:surname": "Voskens",
                                        "ce:indexed-name": "Voskens CJ"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SM",
                                        "@_fa": "true",
                                        "ce:surname": "Goldinger",
                                        "ce:indexed-name": "Goldinger SM"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Loquai",
                                        "ce:indexed-name": "Loquai C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "PLoS One"
                        },
                        "ce:source-text": "Voskens CJ, Goldinger SM, Loquai C, et al. The price of tumor control: An analysis of rare side effects of anti- CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One 2013;8:e53745. 10.1371/ journal.pone.0053745"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Leitinger M, Varosanec MV, Pikija S, et al. Fatal necrotizing encephalopathy after treatment with nivolumab for squamous non-small cell lung cancer: Case report and review of the literature. Front Immunol 2018;9:108. 10.3389/fimmu.2018.00108",
                        "@id": "101",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Fatal necrotizing encephalopathy after treatment with nivolumab for squamous non-small cell lung cancer: Case report and review of the literature"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.3389/fimmu.2018.00108",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041350341",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "108"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Leitinger",
                                        "ce:indexed-name": "Leitinger M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "MV",
                                        "@_fa": "true",
                                        "ce:surname": "Varosanec",
                                        "ce:indexed-name": "Varosanec MV"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Pikija",
                                        "ce:indexed-name": "Pikija S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Front Immunol"
                        },
                        "ce:source-text": "Leitinger M, Varosanec MV, Pikija S, et al. Fatal necrotizing encephalopathy after treatment with nivolumab for squamous non-small cell lung cancer: Case report and review of the literature. Front Immunol 2018;9:108. 10.3389/fimmu.2018.00108"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Kim D. Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer. Clin Case Rep 2019;7:935\u201338. 10.1002/ ccr3.2122",
                        "@id": "102",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1002/ccr3.2122",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85065475852",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "935",
                                    "@last": "938"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "D.",
                                "@_fa": "true",
                                "ce:surname": "Kim",
                                "ce:indexed-name": "Kim D."
                            }]},
                            "ref-sourcetitle": "Clin Case Rep"
                        },
                        "ce:source-text": "Kim D. Posterior reversible encephalopathy syndrome induced by nivolumab immunotherapy for non-small-cell lung cancer. Clin Case Rep 2019;7:935\u201338. 10.1002/ ccr3.2122"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Liao B, Shroff S, Kamiya-Matsuoka C, et al. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014;16:589\u201393. 10.1093/neuonc/nou001",
                        "@id": "103",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/neuonc/nou001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84896934432",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "16"},
                                "pagerange": {
                                    "@first": "589",
                                    "@last": "593"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Liao",
                                        "ce:indexed-name": "Liao B"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Shroff",
                                        "ce:indexed-name": "Shroff S"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Kamiya-Matsuoka",
                                        "ce:indexed-name": "Kamiya-Matsuoka C"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Neuro Oncol"
                        },
                        "ce:source-text": "Liao B, Shroff S, Kamiya-Matsuoka C, et al. Atypical neurological complications of ipilimumab therapy in patients with metastatic melanoma. Neuro Oncol 2014;16:589\u201393. 10.1093/neuonc/nou001"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "O\u2019Kane GM, Lyons TG, Colleran GC, et al. Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma. Oncol Res Treat 2014;37:757\u201360. 10.1159/000368316",
                        "@id": "104",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000368316",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84919828890",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "37"},
                                "pagerange": {
                                    "@first": "757",
                                    "@last": "760"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "GM",
                                        "@_fa": "true",
                                        "ce:surname": "O\u2019Kane",
                                        "ce:indexed-name": "O'Kane GM"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "TG",
                                        "@_fa": "true",
                                        "ce:surname": "Lyons",
                                        "ce:indexed-name": "Lyons TG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "GC",
                                        "@_fa": "true",
                                        "ce:surname": "Colleran",
                                        "ce:indexed-name": "Colleran GC"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Oncol Res Treat"
                        },
                        "ce:source-text": "O\u2019Kane GM, Lyons TG, Colleran GC, et al. Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma. Oncol Res Treat 2014;37:757\u201360. 10.1159/000368316"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Garcia CA, El-Ali A, Rath TJ, et al. Neurologic immunerelated adverse events associated with adjuvant ipilimumab: Report of two cases. J Immunother Cancer 2018;6:83. 10.1186/s40425-018-0393-z",
                        "@id": "105",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Neurologic immunerelated adverse events associated with adjuvant ipilimumab: Report of two cases"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-018-0393-z",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85052640107",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "83"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "CA",
                                        "@_fa": "true",
                                        "ce:surname": "Garcia",
                                        "ce:indexed-name": "Garcia CA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "El-Ali",
                                        "ce:indexed-name": "El-Ali A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "TJ",
                                        "@_fa": "true",
                                        "ce:surname": "Rath",
                                        "ce:indexed-name": "Rath TJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Garcia CA, El-Ali A, Rath TJ, et al. Neurologic immunerelated adverse events associated with adjuvant ipilimumab: Report of two cases. J Immunother Cancer 2018;6:83. 10.1186/s40425-018-0393-z"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Siegel CH, Finn RS, Ho MG. Multiple cranial neuropathies from nivolumab in a patient with metastatic hepatocellular carcinoma. Mayo Clin Proc 2018;93:540\u201341. 10.1016/j. mayocp.2018.01.001",
                        "@id": "106",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Multiple cranial neuropathies from nivolumab in a patient with metastatic hepatocellular carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.mayocp.2018.01.001",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85044108624",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "93"},
                                "pagerange": {
                                    "@first": "540",
                                    "@last": "541"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "CH",
                                    "@_fa": "true",
                                    "ce:surname": "Siegel",
                                    "ce:indexed-name": "Siegel CH"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "RS",
                                    "@_fa": "true",
                                    "ce:surname": "Finn",
                                    "ce:indexed-name": "Finn RS"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "MG.",
                                    "@_fa": "true",
                                    "ce:surname": "Ho",
                                    "ce:indexed-name": "Ho MG."
                                }
                            ]},
                            "ref-sourcetitle": "Mayo Clin Proc"
                        },
                        "ce:source-text": "Siegel CH, Finn RS, Ho MG. Multiple cranial neuropathies from nivolumab in a patient with metastatic hepatocellular carcinoma. Mayo Clin Proc 2018;93:540\u201341. 10.1016/j. mayocp.2018.01.001"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Yuen C, Reid P, Zhang Z, et al. Facial palsy induced by checkpoint blockade: A single center retrospective Study. J Immunother 2019 Apr;42:(3):94\u201396. 10.1097/CJI.00000 00000000254",
                        "@id": "107",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Facial palsy induced by checkpoint blockade: A single center retrospective Study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/CJI.00000",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85059630009",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "42",
                                    "@issue": "3"
                                },
                                "pagerange": {
                                    "@first": "94",
                                    "@last": "96"
                                }
                            },
                            "ref-text": "Apr;: 00000000254",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "C",
                                        "@_fa": "true",
                                        "ce:surname": "Yuen",
                                        "ce:indexed-name": "Yuen C"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "P",
                                        "@_fa": "true",
                                        "ce:surname": "Reid",
                                        "ce:indexed-name": "Reid P"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "Z",
                                        "@_fa": "true",
                                        "ce:surname": "Zhang",
                                        "ce:indexed-name": "Zhang Z"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother"
                        },
                        "ce:source-text": "Yuen C, Reid P, Zhang Z, et al. Facial palsy induced by checkpoint blockade: A single center retrospective Study. J Immunother 2019 Apr;42:(3):94\u201396. 10.1097/CJI.00000 00000000254"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hiraki T, Hatanaka M, Arimura A, et al. Granulomatous/ sarcoid-like reactions in the setting of programmed cell death-1 inhibition: A potential mimic of disease recurrence. J Cutan Pathol 2020;47:154\u201360. 10.1111/cup.13569",
                        "@id": "108",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Granulomatous/ sarcoid-like reactions in the setting of programmed cell death-1 inhibition: A potential mimic of disease recurrence"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1111/cup.13569",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85071516007",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "47"},
                                "pagerange": {
                                    "@first": "154",
                                    "@last": "160"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Hiraki",
                                        "ce:indexed-name": "Hiraki T"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Hatanaka",
                                        "ce:indexed-name": "Hatanaka M"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Arimura",
                                        "ce:indexed-name": "Arimura A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Cutan Pathol"
                        },
                        "ce:source-text": "Hiraki T, Hatanaka M, Arimura A, et al. Granulomatous/ sarcoid-like reactions in the setting of programmed cell death-1 inhibition: A potential mimic of disease recurrence. J Cutan Pathol 2020;47:154\u201360. 10.1111/cup.13569"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tetzlaff MT, Nelson KC, Diab A, et al. Granulomatous/ sarcoid-like lesions associated with checkpoint inhibitors: A marker of therapy response in a subset of melanoma patients. J Immunother Cancer 2018;6:14. 10.1186/s40425- 018-0323-0 [29433571 10.1186/s40425-018-0323-0",
                        "@id": "109",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Granulomatous/ sarcoid-like lesions associated with checkpoint inhibitors: A marker of therapy response in a subset of melanoma patients"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-018-0323-0",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85041950037",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "14"}
                            },
                            "ref-text": "10.1186/s40425 018-0323-0, [29433571",
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "MT",
                                        "@_fa": "true",
                                        "ce:surname": "Tetzlaff",
                                        "ce:indexed-name": "Tetzlaff MT"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "KC",
                                        "@_fa": "true",
                                        "ce:surname": "Nelson",
                                        "ce:indexed-name": "Nelson KC"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Diab",
                                        "ce:indexed-name": "Diab A"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Tetzlaff MT, Nelson KC, Diab A, et al. Granulomatous/ sarcoid-like lesions associated with checkpoint inhibitors: A marker of therapy response in a subset of melanoma patients. J Immunother Cancer 2018;6:14. 10.1186/s40425- 018-0323-0 [29433571 10.1186/s40425-018-0323-0"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Rambhia PH, Reichert B, Scott JF, et al. Immune checkpoint inhibitor-induced sarcoidosis-like granulomas. Int J Clin Oncol 2019;24:1171\u201381. 10.1007/s10147-019-01490-2",
                        "@id": "110",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune checkpoint inhibitor-induced sarcoidosis-like granulomas"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s10147-019-01490-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85069503866",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "1171",
                                    "@last": "1181"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PH",
                                        "@_fa": "true",
                                        "ce:surname": "Rambhia",
                                        "ce:indexed-name": "Rambhia PH"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Reichert",
                                        "ce:indexed-name": "Reichert B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "JF",
                                        "@_fa": "true",
                                        "ce:surname": "Scott",
                                        "ce:indexed-name": "Scott JF"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Clin Oncol"
                        },
                        "ce:source-text": "Rambhia PH, Reichert B, Scott JF, et al. Immune checkpoint inhibitor-induced sarcoidosis-like granulomas. Int J Clin Oncol 2019;24:1171\u201381. 10.1007/s10147-019-01490-2"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Dunn-Pirio AM, Shah S, Eckstein C. Neurosarcoidosis following immune checkpoint inhibition. Case Rep Oncol 2018;11:521\u201326. 10.1159/000491599",
                        "@id": "111",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Neurosarcoidosis following immune checkpoint inhibition"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1159/000491599",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85052663649",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "11"},
                                "pagerange": {
                                    "@first": "521",
                                    "@last": "526"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AM",
                                    "@_fa": "true",
                                    "ce:surname": "Dunn-Pirio",
                                    "ce:indexed-name": "Dunn-Pirio AM"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S",
                                    "@_fa": "true",
                                    "ce:surname": "Shah",
                                    "ce:indexed-name": "Shah S"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Eckstein",
                                    "ce:indexed-name": "Eckstein C."
                                }
                            ]},
                            "ref-sourcetitle": "Case Rep Oncol"
                        },
                        "ce:source-text": "Dunn-Pirio AM, Shah S, Eckstein C. Neurosarcoidosis following immune checkpoint inhibition. Case Rep Oncol 2018;11:521\u201326. 10.1159/000491599"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tan I, Malinzak M, Salama AKS. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy. J Immunother Cancer 2018;6:77. 10.1186/s40425- 018-0390-2",
                        "@id": "112",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s40425-018-0390-2",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85050756876",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {"@first": "77"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "I",
                                    "@_fa": "true",
                                    "ce:surname": "Tan",
                                    "ce:indexed-name": "Tan I"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "M",
                                    "@_fa": "true",
                                    "ce:surname": "Malinzak",
                                    "ce:indexed-name": "Malinzak M"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "AKS.",
                                    "@_fa": "true",
                                    "ce:surname": "Salama",
                                    "ce:indexed-name": "Salama AKS."
                                }
                            ]},
                            "ref-sourcetitle": "J Immunother Cancer"
                        },
                        "ce:source-text": "Tan I, Malinzak M, Salama AKS. Delayed onset of neurosarcoidosis after concurrent ipilimumab/nivolumab therapy. J Immunother Cancer 2018;6:77. 10.1186/s40425- 018-0390-2"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Cheshire SC, Board RE, Lewis AR, et al. Pembrolizumabinduced sarcoid-like reactions during treatment of metastatic melanoma. Radiology 2018;289:564\u201367. 10.1148/radiol. 2018180572",
                        "@id": "113",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Pembrolizumabinduced sarcoid-like reactions during treatment of metastatic melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1148/radiol.2018180572",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85055079859",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "289"},
                                "pagerange": {
                                    "@first": "564",
                                    "@last": "567"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "SC",
                                        "@_fa": "true",
                                        "ce:surname": "Cheshire",
                                        "ce:indexed-name": "Cheshire SC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "RE",
                                        "@_fa": "true",
                                        "ce:surname": "Board",
                                        "ce:indexed-name": "Board RE"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "AR",
                                        "@_fa": "true",
                                        "ce:surname": "Lewis",
                                        "ce:indexed-name": "Lewis AR"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Radiology"
                        },
                        "ce:source-text": "Cheshire SC, Board RE, Lewis AR, et al. Pembrolizumabinduced sarcoid-like reactions during treatment of metastatic melanoma. Radiology 2018;289:564\u201367. 10.1148/radiol. 2018180572"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Fang T, Maberley DA, Etminan M. Ocular adverse events with immune checkpoint inhibitors. J Curr Ophthalmol 2019;31:319\u201322. 10.1016/j.joco.2019.05.002",
                        "@id": "114",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Ocular adverse events with immune checkpoint inhibitors"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.joco.2019.05.002",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85066937042",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "31"},
                                "pagerange": {
                                    "@first": "319",
                                    "@last": "322"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "T",
                                    "@_fa": "true",
                                    "ce:surname": "Fang",
                                    "ce:indexed-name": "Fang T"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "DA",
                                    "@_fa": "true",
                                    "ce:surname": "Maberley",
                                    "ce:indexed-name": "Maberley DA"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Etminan",
                                    "ce:indexed-name": "Etminan M."
                                }
                            ]},
                            "ref-sourcetitle": "J Curr Ophthalmol"
                        },
                        "ce:source-text": "Fang T, Maberley DA, Etminan M. Ocular adverse events with immune checkpoint inhibitors. J Curr Ophthalmol 2019;31:319\u201322. 10.1016/j.joco.2019.05.002"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Dalvin LA, Shields CL, Orloff M, et al. Checkpoint inhibitor immune therapy: Systemic indications and ophthalmic side effects. Retina 2018;38:1063\u201378. 10.1097/IAE.0000000000002181",
                        "@id": "115",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Checkpoint inhibitor immune therapy: Systemic indications and ophthalmic side effects"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1097/IAE.0000000000002181",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85049382652",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "38"},
                                "pagerange": {
                                    "@first": "1063",
                                    "@last": "1078"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "LA",
                                        "@_fa": "true",
                                        "ce:surname": "Dalvin",
                                        "ce:indexed-name": "Dalvin LA"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "CL",
                                        "@_fa": "true",
                                        "ce:surname": "Shields",
                                        "ce:indexed-name": "Shields CL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Orloff",
                                        "ce:indexed-name": "Orloff M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Retina"
                        },
                        "ce:source-text": "Dalvin LA, Shields CL, Orloff M, et al. Checkpoint inhibitor immune therapy: Systemic indications and ophthalmic side effects. Retina 2018;38:1063\u201378. 10.1097/IAE.0000000000002181"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Hansen AR, Siu LL. PD-L1 testing in cancer: Challenges in companion diagnostic development. JAMA Oncol 2016;2:15\u2013",
                        "@id": "116",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "PD-L1 testing in cancer: Challenges in companion diagnostic development"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84973502995",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "2"},
                                "pagerange": {"@first": "15"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AR",
                                    "@_fa": "true",
                                    "ce:surname": "Hansen",
                                    "ce:indexed-name": "Hansen AR"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "LL.",
                                    "@_fa": "true",
                                    "ce:surname": "Siu",
                                    "ce:indexed-name": "Siu LL."
                                }
                            ]},
                            "ref-sourcetitle": "JAMA Oncol"
                        },
                        "ce:source-text": "Hansen AR, Siu LL. PD-L1 testing in cancer: Challenges in companion diagnostic development. JAMA Oncol 2016;2:15\u2013"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "10.1001/jamaoncol.2015.4685",
                        "@id": "117",
                        "ref-info": {"refd-itemidlist": {"itemid": [
                            {
                                "$": "10.1001/jamaoncol.2015.4685",
                                "@idtype": "DOI"
                            },
                            {
                                "$": "85100904341",
                                "@idtype": "SGR"
                            }
                        ]}},
                        "ce:source-text": "10.1001/jamaoncol.2015.4685"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Ngamphaiboon N, Chureemas T, Siripoon T, et al. Characteristics and impact of programmed death-ligand 1 expression, CD8þ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma. Med Oncol 2019;36:21. 10.1007/s12032-018-1241-1",
                        "@id": "118",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Characteristics and impact of programmed death-ligand 1 expression, CD8þ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s12032-018-1241-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85060241230",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "36"},
                                "pagerange": {"@first": "21"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "N",
                                        "@_fa": "true",
                                        "ce:surname": "Ngamphaiboon",
                                        "ce:indexed-name": "Ngamphaiboon N"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Chureemas",
                                        "ce:indexed-name": "Chureemas T"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "T",
                                        "@_fa": "true",
                                        "ce:surname": "Siripoon",
                                        "ce:indexed-name": "Siripoon T"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Med Oncol"
                        },
                        "ce:source-text": "Ngamphaiboon N, Chureemas T, Siripoon T, et al. Characteristics and impact of programmed death-ligand 1 expression, CD8þ tumor-infiltrating lymphocytes, and p16 status in head and neck squamous cell carcinoma. Med Oncol 2019;36:21. 10.1007/s12032-018-1241-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Palucka AK, Coussens LM. The basis of oncoimmunology. Cell 2016;164:1233\u201347. 10.1016/j.cell.2016.01.049",
                        "@id": "119",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "The basis of oncoimmunology"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/j.cell.2016.01.049",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "84960422665",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "164"},
                                "pagerange": {
                                    "@first": "1233",
                                    "@last": "1247"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "AK",
                                    "@_fa": "true",
                                    "ce:surname": "Palucka",
                                    "ce:indexed-name": "Palucka AK"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "LM.",
                                    "@_fa": "true",
                                    "ce:surname": "Coussens",
                                    "ce:indexed-name": "Coussens LM."
                                }
                            ]},
                            "ref-sourcetitle": "Cell"
                        },
                        "ce:source-text": "Palucka AK, Coussens LM. The basis of oncoimmunology. Cell 2016;164:1233\u201347. 10.1016/j.cell.2016.01.049"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Oliva M, Spreafico A, Taberna M, et al. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Ann Oncol 2019;30:57\u201367. 10.1093/annonc/mdy507",
                        "@id": "120",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdy507",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85060150970",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "57",
                                    "@last": "67"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Oliva",
                                        "ce:indexed-name": "Oliva M"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "A",
                                        "@_fa": "true",
                                        "ce:surname": "Spreafico",
                                        "ce:indexed-name": "Spreafico A"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Taberna",
                                        "ce:indexed-name": "Taberna M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Oliva M, Spreafico A, Taberna M, et al. Immune biomarkers of response to immune-checkpoint inhibitors in head and neck squamous cell carcinoma. Ann Oncol 2019;30:57\u201367. 10.1093/annonc/mdy507"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: An imaging biomarker, retrospective multicohort study. Lancet Oncol 2018;19:1180\u201391. 10.1016/S1470-2045(18) 30413-3",
                        "@id": "121",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: An imaging biomarker, retrospective multicohort study"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1016/S1470-2045(18)30413-3",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85052936565",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "19"},
                                "pagerange": {
                                    "@first": "1180",
                                    "@last": "1191"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "R",
                                        "@_fa": "true",
                                        "ce:surname": "Sun",
                                        "ce:indexed-name": "Sun R"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EJ",
                                        "@_fa": "true",
                                        "ce:surname": "Limkin",
                                        "ce:indexed-name": "Limkin EJ"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "M",
                                        "@_fa": "true",
                                        "ce:surname": "Vakalopoulou",
                                        "ce:indexed-name": "Vakalopoulou M"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Lancet Oncol"
                        },
                        "ce:source-text": "Sun R, Limkin EJ, Vakalopoulou M, et al. A radiomics approach to assess tumour-infiltrating CD8 cells and response to anti-PD-1 or anti-PD-L1 immunotherapy: An imaging biomarker, retrospective multicohort study. Lancet Oncol 2018;19:1180\u201391. 10.1016/S1470-2045(18) 30413-3"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Trebeschi S, Drago SG, Birkbak NJ, et al. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol 2019;30:998\u20131004. 10.1093/annonc/mdz108",
                        "@id": "122",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdz108",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85070450750",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "30"},
                                "pagerange": {
                                    "@first": "998",
                                    "@last": "1004"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Trebeschi",
                                        "ce:indexed-name": "Trebeschi S"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "SG",
                                        "@_fa": "true",
                                        "ce:surname": "Drago",
                                        "ce:indexed-name": "Drago SG"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "NJ",
                                        "@_fa": "true",
                                        "ce:surname": "Birkbak",
                                        "ce:indexed-name": "Birkbak NJ"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        },
                        "ce:source-text": "Trebeschi S, Drago SG, Birkbak NJ, et al. Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers. Ann Oncol 2019;30:998\u20131004. 10.1093/annonc/mdz108"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "van de Donk PP, Kist de Ruijter L, Lub-de Hooge MN, et al. Molecular imaging biomarkers for immune checkpoint inhibitor therapy. Theranostics 2020;10:1708\u201318. 10.7150/ thno.38339",
                        "@id": "123",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2020"},
                            "ref-title": {"ref-titletext": "Molecular imaging biomarkers for immune checkpoint inhibitor therapy"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.7150/thno.38339",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85077682980",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "10"},
                                "pagerange": {
                                    "@first": "1708",
                                    "@last": "1718"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "PP",
                                        "@_fa": "true",
                                        "ce:surname": "van de Donk",
                                        "ce:indexed-name": "van de Donk PP"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Kist de Ruijter",
                                        "ce:indexed-name": "Kist de Ruijter L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MN",
                                        "@_fa": "true",
                                        "ce:surname": "Lub-de Hooge",
                                        "ce:indexed-name": "Lub-de Hooge MN"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Theranostics"
                        },
                        "ce:source-text": "van de Donk PP, Kist de Ruijter L, Lub-de Hooge MN, et al. Molecular imaging biomarkers for immune checkpoint inhibitor therapy. Theranostics 2020;10:1708\u201318. 10.7150/ thno.38339"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Goldfarb L, Duchemann B, Chouahnia K, et al. Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: Introduction of iPERCIST. EJNMMI Res 2019;9:8. 10.1186/s13550-019-0473-1",
                        "@id": "124",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2019"},
                            "ref-title": {"ref-titletext": "Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: Introduction of iPERCIST"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1186/s13550-019-0473-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85060866855",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "9"},
                                "pagerange": {"@first": "8"}
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Goldfarb",
                                        "ce:indexed-name": "Goldfarb L"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "B",
                                        "@_fa": "true",
                                        "ce:surname": "Duchemann",
                                        "ce:indexed-name": "Duchemann B"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "K",
                                        "@_fa": "true",
                                        "ce:surname": "Chouahnia",
                                        "ce:indexed-name": "Chouahnia K"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "EJNMMI Res"
                        },
                        "ce:source-text": "Goldfarb L, Duchemann B, Chouahnia K, et al. Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: Introduction of iPERCIST. EJNMMI Res 2019;9:8. 10.1186/s13550-019-0473-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Grizzi F, Castello A, Lopci E. Is it time to change our vision of tumor metabolism prior to immunotherapy? Eur J Nucl Med Mol Imaging 2018;45:1072\u201375. 10.1007/s00259-018- 3988-1",
                        "@id": "125",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "Is it time to change our vision of tumor metabolism prior to immunotherapy?"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1007/s00259-018-3988-1",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85043454413",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "45"},
                                "pagerange": {
                                    "@first": "1072",
                                    "@last": "1075"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F",
                                    "@_fa": "true",
                                    "ce:surname": "Grizzi",
                                    "ce:indexed-name": "Grizzi F"
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A",
                                    "@_fa": "true",
                                    "ce:surname": "Castello",
                                    "ce:indexed-name": "Castello A"
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Lopci",
                                    "ce:indexed-name": "Lopci E."
                                }
                            ]},
                            "ref-sourcetitle": "Eur J Nucl Med Mol Imaging"
                        },
                        "ce:source-text": "Grizzi F, Castello A, Lopci E. Is it time to change our vision of tumor metabolism prior to immunotherapy? Eur J Nucl Med Mol Imaging 2018;45:1072\u201375. 10.1007/s00259-018- 3988-1"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Tan AC, Emmett L, Lo S, et al. FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma. AnnOncol 2018;29:2115\u201320. 10.1093/annonc/mdy330",
                        "@id": "126",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1093/annonc/mdy330",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85053328524",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "29"},
                                "pagerange": {
                                    "@first": "2115",
                                    "@last": "2120"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "AC",
                                        "@_fa": "true",
                                        "ce:surname": "Tan",
                                        "ce:indexed-name": "Tan AC"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "L",
                                        "@_fa": "true",
                                        "ce:surname": "Emmett",
                                        "ce:indexed-name": "Emmett L"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S",
                                        "@_fa": "true",
                                        "ce:surname": "Lo",
                                        "ce:indexed-name": "Lo S"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "AnnOncol"
                        },
                        "ce:source-text": "Tan AC, Emmett L, Lo S, et al. FDG-PET response and outcome from anti-PD-1 therapy in metastatic melanoma. AnnOncol 2018;29:2115\u201320. 10.1093/annonc/mdy330"
                    },
                    {
                        "@aii:was-generated-by": "http://data.elsevier.com/art/structure-references art:version v1.0.181",
                        "ref-fulltext": "Bensch F, van der Veen EL, Lub-de Hooge MN, et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat Med 2018;24:1852\u201358. 10.1038/s41591-018-0255-8",
                        "@id": "127",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2018"},
                            "ref-title": {"ref-titletext": "89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "10.1038/s41591-018-0255-8",
                                    "@idtype": "DOI"
                                },
                                {
                                    "$": "85057312151",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {
                                "voliss": {"@volume": "24"},
                                "pagerange": {
                                    "@first": "1852",
                                    "@last": "1858"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "F",
                                        "@_fa": "true",
                                        "ce:surname": "Bensch",
                                        "ce:indexed-name": "Bensch F"
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "EL",
                                        "@_fa": "true",
                                        "ce:surname": "van der Veen",
                                        "ce:indexed-name": "van der Veen EL"
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "MN",
                                        "@_fa": "true",
                                        "ce:surname": "Lub-de Hooge",
                                        "ce:indexed-name": "Lub-de Hooge MN"
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Nat Med"
                        },
                        "ce:source-text": "Bensch F, van der Veen EL, Lub-de Hooge MN, et al. 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer. Nat Med 2018;24:1852\u201358. 10.1038/s41591-018-0255-8"
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60199578",
            "affilname": "Ramathibodi Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60021600",
            "affilname": "University of Toronto Faculty of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021600",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60006894",
            "affilname": "Mount Sinai Hospital of University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006894",
            "affiliation-country": "Canada"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85100905088",
        "dc:description": "Immune checkpoint inhibitors have revolutionized treatment in many cancers, including head and neck squamous cell carcinoma. The number of drugs recently approved by the FDA and the European Medicine Agency is growing. Pembrolizumab and nivolumab, which are anti-programmed cell death protein 1 monoclonal antibodies, were first adopted in 2016 as the second-line treatment for recurrent or metastatic head and neck squamous cell carcinoma in patients with disease progression after platinum-based chemotherapy. Recently, pembrolizumab with or without platinum-based chemotherapy was approved as the first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma. Imaging studies play an essential role in assessing treatment response and monitoring efficacy and safety during and after treatments. Given the rapid increase in the use of immunotherapy in head and neck squamous cell carcinoma, neuroradiologists need to be familiar with the unique features indicative of treatment response in addition to a broad array of immune-related adverse events to avoid misinterpreting secondary drug-related adverse effects as tumor progression or metastasis. Moreover, emerging imaging techniques, including molecular imaging and radiomics, in an effort to assess or gauge the likelihood of treatment response to immune checkpoint inhibitors, is an ongoing area of active research.",
        "prism:coverDate": "2020-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85100905088",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Sananmuang",
                "ce:indexed-name": "Sananmuang T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:degrees": "MD",
            "ce:surname": "Sananmuang",
            "@auid": "57219223585",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219223585",
            "ce:indexed-name": "Sananmuang T."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85100905088"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85100905088&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85100905088&origin=inward"
            }
        ],
        "source-id": "21101034071",
        "citedby-count": "0",
        "prism:volume": "10",
        "subtype": "ar",
        "dc:title": "Immune checkpoint inhibitor: An emerging treatment for head and neck cancer. a primer for the radiologist",
        "openaccess": "0",
        "prism:issn": "26378329",
        "publishercopyright": "© 2020, American Society of Neuroradiology. All rights reserved.",
        "prism:issueIdentifier": "5-6",
        "subtypeDescription": "Article",
        "prism:publicationName": "Neurographics",
        "prism:pageRange": "284-301",
        "prism:endingPage": "301",
        "openaccessFlag": "false",
        "prism:doi": "10.3174/ng.2000016",
        "prism:startingPage": "284",
        "dc:identifier": "SCOPUS_ID:85100905088",
        "dc:publisher": "American Society of Neuroradiology"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": null,
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Radiology, Nuclear Medicine and Imaging",
        "@code": "2741",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "T.",
                "ce:initials": "T.",
                "ce:surname": "Sananmuang",
                "ce:indexed-name": "Sananmuang T."
            },
            "@seq": "1",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:degrees": "MD",
            "ce:surname": "Sananmuang",
            "@auid": "57219223585",
            "author-url": "https://api.elsevier.com/content/author/author_id/57219223585",
            "ce:indexed-name": "Sananmuang T."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Prakkamakul",
                "ce:indexed-name": "Prakkamakul S."
            },
            "@seq": "2",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60028190",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
                },
                {
                    "@id": "60022183",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"
                }
            ],
            "ce:surname": "Prakkamakul",
            "@auid": "55788265500",
            "author-url": "https://api.elsevier.com/content/author/author_id/55788265500",
            "ce:indexed-name": "Prakkamakul S."
        },
        {
            "preferred-name": {
                "ce:given-name": "N.",
                "ce:initials": "N.",
                "ce:surname": "Ngampaiboon",
                "ce:indexed-name": "Ngampaiboon N."
            },
            "@seq": "3",
            "ce:initials": "N.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60199578",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60199578"
            },
            "ce:surname": "Ngampaiboon",
            "@auid": "57221996014",
            "author-url": "https://api.elsevier.com/content/author/author_id/57221996014",
            "ce:indexed-name": "Ngampaiboon N."
        },
        {
            "preferred-name": {
                "ce:given-name": "S. H.",
                "ce:initials": "S.H.",
                "ce:surname": "Huang",
                "ce:indexed-name": "Huang S.H."
            },
            "@seq": "4",
            "ce:initials": "S.H.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60021600",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021600"
            },
            "ce:surname": "Huang",
            "@auid": "57202335059",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202335059",
            "ce:indexed-name": "Huang S.H."
        },
        {
            "preferred-name": {
                "ce:given-name": "L.",
                "ce:initials": "L.",
                "ce:surname": "Alshafai",
                "ce:indexed-name": "Alshafai L."
            },
            "@seq": "5",
            "ce:initials": "L.",
            "@_fa": "true",
            "affiliation": [
                {
                    "@id": "60016849",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849"
                },
                {
                    "@id": "60006894",
                    "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006894"
                }
            ],
            "ce:surname": "Alshafai",
            "@auid": "57189364833",
            "author-url": "https://api.elsevier.com/content/author/author_id/57189364833",
            "ce:indexed-name": "Alshafai L."
        },
        {
            "preferred-name": {
                "ce:given-name": "E.",
                "ce:initials": "E.",
                "ce:surname": "Yu From",
                "ce:indexed-name": "Yu From E."
            },
            "@seq": "6",
            "ce:initials": "E.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016849",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849"
            },
            "ce:surname": "Yu From",
            "@auid": "57222001929",
            "author-url": "https://api.elsevier.com/content/author/author_id/57222001929",
            "ce:indexed-name": "Yu From E."
        }
    ]}
}}